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Characterization of  Bioeffects on Endothelial Cells Under 
Acoustic Droplet Vaporization 
 
By Robinson Seda-Padilla 
An ultrasound-mediated cancer treatment called gas embolotherapy has the potential 
for providing selective occlusion of  blood vessels for therapy.  Vessel occlusion is 
achieved by locally vaporizing micron-sized droplets through acoustic droplet 
vaporization (ADV), which results in bubbles that are large enough to occlude blood 
flow directed to tumors.  Endothelial cells, lining of  our blood vessels, will be 
directly affected by these vaporization events and as such are the subject of  this study.  
Damage to the endothelium could lead to a number of  pathological states that, if  left 
untreated could be harmful.  However, if  under control, these bioeffects could 
provide benefits that would be synergistic with bubble occlusion like increased 
endothelial permeability or occlusion by thrombosis.  We investigate bioeffects 




Two insonation frequencies (3.5 MHz and 7.5 MHz) were chosen to characterize 
the effects of  ADV and aid in the exploration of  frequency dependent effects.  
Damage was observed through changes in peak-negative (rarefactional) pressure and 
pulse length, and described by the absence of  cells after treatment.  Damage was 
dependent in bubble cloud area and highly localized.  Additional data was obtained 
to elucidate the role of  ADV in open or confined environments, which simulate 
relatively large and small vessels, respectively.  Through these experiments we try to 
provide the reader with some of  the tools necessary to make an assessment on the 
repercussions of  performing ADV in situations that allow the droplets and ultimately 
the bubbles, to be in direct contact with the endothelium.  Knowing when 
significant damage is expected in gas embolotherapy could help in the development 













Embolotherapy is the intentional injection of  a blocking agent (embolus) to slow or 
stop the blood flow for therapeutic purposes.  It has been shown that permanent 
damage to tissue is possible if  enough solid emboli are delivered or sufficient 
occlusion can be achieved during the therapy [1, 2].  Embolotherapy can also be 
implemented in conjunction with drug-releasing emboli for localized drug delivery.  
Some potential applications of  embolotherapy include hemorrhage, and some types 
of  cancers, such as hepatocellular carcinoma (HCC), and hypervascular tumors such 
as renal cell carcinoma [3].  HCC for example, has been treated more effectively 
using embolotherapy than using chemotherapy or resection [4]. However, 
embolotherapy is only used as a last resort after conventional treatments have failed.   
The success of  embolotherapy greatly depends on several factors, such as the 
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selection of  the embolic agent, the application and the ability to direct and confine 
the emboli to the targeted area [3].  Unfortunately, all of  these factors present 
unique challenges that need to be taken into consideration.  For example, the 
selection of  the embolus can be quite difficult.  They can be extremely toxic and 
painful (e.g. ethanol), permanent (e.g. n-butyl cyanoacrylate), thrombogenic (e.g. 
coils and balloons) or non-target specific (e.g. microspheres).  In addition to the 
selection and confinement of  the emboli, some embolotherapy procedures may 
involve more complicated and invasive work, exposing the patient to other health 
risks.  Future embolic agents need to be non-toxic, easily transported and 
target-specific in order to provide a more robust, localized and less invasive therapy.  
Consequently, there is a need for improving current embolotherapy techniques.  
Gas embolotherapy (GE) is a minimally invasive procedure that provides means 
for selective occlusion of  blood vessels and offers relief  to most of  the disadvantages 
encountered in conventional embolotherapy techniques [5, 6, 7].  The principle 
behind GE is the use of  albumin (or lipid)-coated microdroplets that are vaporized 
locally to provide gas emboli [8, 9, 10].  These droplets are small enough to pass 
through the microcirculation (d < 6 µm), thus avoiding the risk of  occlusion of  
vessels feeding healthy tissue.  These bubbles are generated using focused ultrasound 
(US) via acoustic droplet vaporization (ADV) [8, 10, 11].  During this process 
(Figure 1), microdroplets, with a dodecafuoropentane (DDFP, C5F12) core are 
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Table 1.1: Physical Properties of  Dodecafluoropentane (C5F12) 
Property Value 
Molecular weight  288 g/mol 
Boiling point  29ºC 
Density  1630 kg/m3 
Viscosity  0.00652 N s/m2 
Surface tension  0.7 N/m 
 
injected into the bloodstream and allowed to circulate the body until an area (tumor) 
has been targeted.  DDFP (29ºC boiling point) is a perfluorocarbon (PFC) capable 
of  undergoing vaporization at body temperature due to its level of  superheat, but it is 
stabilized by the albumin or lipid shell.  Table 1.1 summarizes the physical 










Once the cancerous tissue has been targeted (with the aid of  imaging tools) and 
the vaporization threshold is reached, the ADV process will take place.   This 
process will be capable of  transforming these microdroplets into bubbles that are 125 
to nearly 150 times their original volume capable of  occluding blood vessels feeding 
the tumor [8].  A focused US transducer will make possible that vaporization of  
these droplets and subsequent occlusion will only occur at or near the tumor reducing 
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the risk of  collateral damage.  Also, due to the low solubility of  PFC gases in water, 
a large number of  these bubbles will be able to provide prolonged occlusion to cause 
tumor infarction.  While it was previously stated that the ADV process would be 
localized, there are still some important things to consider, which are subject of  this 
dissertation.  High pressures and shear stresses generated during this event (i.e. 
phase transition and bubble expansion processes), capable of  affecting blood cells 
and the vessel wall, are examples of  important considerations that may affect the 
advancement of  this therapy.  Therefore, we focus our efforts in investigating the 
impact of  ADV on the vessel wall.        
Some of  the first studies addressing the potential impact of  ADV on the anatomy 
of  a blood vessel showed the results of  two direct numerical simulations that 
recreated the bubble expansion process following ADV in a rigid and flexible tube [12, 
13].  Pressures and shear stresses were found to be much higher in the rigid tube 
case compared to the flexible tube suggesting that flexibility of  the vessels might have 
a dampening effect.  A limitation of  this study was the lack of  an appropriate 
internal bubble pressure condition (due to unavailable empirical data), which yielded 
rather high results.  However, both studies are relevant to our application because 
they show the role of  blood vessel flexibility and its impact on bubble expansion and 
possible implications on the cellular response.  Our blood vessels are naturally 
flexible, but the level of  flexibility depends on their type and size.  Capillaries, for 
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example, are stiffer because they lack smooth muscle and are embedded in 
surrounding tissue.  Consequently, if  vaporization occurred in small, rigid vessels 
close to the targeted area, high wall stresses could develop.  These stresses in 
conjunction with vessel wall strength may lead to rupture, petechial hemorrhage or 
even cell death.  On the other hand, if  vaporization occurred in relatively large 
(flexible) vessels, stresses will be dampened out, but direction and confinement of  the 
emboli will be lost jeopardizing the selectivity of  the therapy.   
Gas bodies formed as a result of  ADV provide means for yet other important 
biological effects (bioeffects) when interacting with US pulses.  A review article 
described these bioeffects considering diagnostic US and contrast agents [14].  
When in contact with contrast agents, US produces microbubble pulsations that can 
trigger cavitation events (stable or transient) that could be harmful to surrounding 
tissue [15, 14].  These events may involve the expansion of  the gas bubble followed 
by a violent collapse driven by the inertia of  the inrushing fluid, which is the case in 
transient (or inertial) cavitation.  Many bioeffects have been associated with inertial 
cavitation (IC), including cell death, vessel rupture, hemorrhage and platelet 
aggregation [14, 16].  Other effects related to microbubbles driven by US pulses, 
which may not be so undesirable, include angiogenesis, remodeling of  vessels and 
increased cell permeability [17, 18, 19].  For example, studies have found that the 
use of  US and contrast agents, such as microbubbles, may facilitate the delivery and 
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increase the endothelial uptake of  several molecular species, such as calcium, nitric 
oxide and growth factors, such as VEGF (vascular endothelial growth factor) [2, 20, 
21, 22, 23].  These studies demonstrated that the interaction between US and 
microbubbles does increase the permeability of  cells through what has been referred 
to as sonoporation [24, 25].   However, it was found that reduced cell viability [26, 
27] and other altered cellular responses have also been observed [28].  Reduced 
viability has been attributed to this US-microbubble interaction capable of  generating 
high temperatures, pressures and fluid velocities [29, 30, 31].   
While the aforementioned bioeffects were generated by the interaction of  an 
acoustic field and preexisting bubbles, it is important to emphasize that ADV will go 
through different stages before a stable bubble is formed.  We believe that the ADV 
process may generate other bioeffects that may be unknown in addition to those 
generated by an US-microbubble interaction, while providing the added advantage of  
vessel occlusion (Figure 1.3).  In addition, it is vital to understand that although 
most of  these vaporization events are limited to the blood vessels, these bioeffects 
could magnify and propagate elsewhere [17, 18].  More specifically, the 
endothelium, as one of  the possible targets during ADV and main subject of  this 
dissertation, could give rise to a cascade of  events that could affect a number of  vital 
bodily functions.  A more detailed description of  these effects is provided in section 
1.2.   
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Knowing the degree of  these effects may be important for multiple reasons.  For 
instance, as GE is in its early investigative stages, it will be important to know what 
the potential pitfalls of  this technique are as well as when and where these are more 
likely to occur.  This is not only interesting, it is also necessary for subsequent 
improvement of  this therapy.  Alternatively, these bioeffects could potentially be 
used as new mechanisms for enhancing drug delivery to the tumor through 
permeabilization of  the endothelial wall.  It has been shown that permeabilization 
of  the endothelial wall is possible when US is applied to thin-shelled microbubbles in 
vivo, which can aid in the delivery of  drugs and genes through regions in the body 
where the endothelial wall is highly impermeable, such as the blood brain barrier [32, 
33, 34, 35].   
1.2 Significance 
The endothelium is a very thin layer of  cells that covers the lumen of  our blood 
vessels (Figure 1.2).  It is composed of  endothelial cells (ECs), which are constantly 
exposed to mechanical (pressure, shear) and hormonal stimuli associated with the 
blood flow [36, 37].  They adapt and respond to these stimuli by signaling cascades 
that can lead to different events such as cytoskeleton reorganization, release of  
cytokines, up and down regulation of  protein expression, cell division and 
programmed cell death (apoptosis) [17, 38].  Depending on their location ECs may 
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experience a level of  shear stresses in the range of  5-20 dyne/cm2 (in major vessels) 
average pressures of  around 120 mmHg (for the systolic phase) and up to 24% of  
deformation [17, 37].  However, several studies have shown that ECs may respond 
and adapt to an increase in these normal levels of  stresses and that their response is 
dependent on the location of  ECs around the cardiovascular circuitry in the body 
[39].  For example, ECs experiencing laminar flow shear stresses might decrease the 
rate of  cell proliferation, while those subjected to altered flow shear stresses, as 
observed in the aortic arch or stenotic vessels, will increase DNA synthesis and cell 
proliferation [36].  The endothelium is a also regulator of  vascular homeostasis 
because it acts as selective barrier, reduces turbulence and play vital roles in other 
physiological events, such as white blood cell migration, coagulation, angiogenesis 
and vasoactive functions by the secretion of  important signaling molecules like 
nitric-oxide (NO).  Damage to the endothelium can lead to endothelial dysfunction, an 
important cardiovascular risk factor. 
During endothelial dysfucntion, ECs reduce their ability to secrete nitric oxide 
(NO) [40], leading to impairment of  vasodilation, which reduces the ability of  the 
blood vessels to relax and decrease vascular resistance.  There is also an increase in 
endothelial permeability, platelet aggregation and leukocyte adhesion; events that 
promote atherosclerosis [41], (Figure 1.4).  This pathological state can be quite serious 
if  necessary measures are not taken, yet it could be a great tool if  used intelligently in 
9 
 
conjunction with available cancer treatments, especially GE.  Local platelet 
aggregation, clotting and thrombosis, for example, could potentially be beneficial if  
vessels supplying the tumor are affected.  This could provide a parallel mechanism 
for vessel occlusion without additional vaporization.   
It is known that ECs are more stable than cancer cells and as such have been 
pursued as possible targets for anti-angiogenic therapies to treat tumors using the 
anti-VEGF monoclonal antibody [42].  This antibody blocks VEGF, which is a 
chemical signal that stimulates blood vessel growth.  However, recent studies [43] 
have shown that ECs growing within a tumor might develop genetic abnormalities 
that could make them more resistant to these therapies.  Therefore, local mechanical 
injury caused by high stresses, preferably through ADV, could potentially be more 
effective.   
Through this set of  experiments we intended to identify some of  the bioeffects of  
GE on ECs by investigating the direct impact of  ADV on a cultured monolayer.  
The main focus is primarily to determine the extent of  the damage once ADV is 
triggered, its immediate effect on cell viability and differences between peak-negative 
pressure (PNP), pulse length and insonation frequencies.  Vaporization at two levels 
of  confinement in the presence of  ECs is also investigated to provide a broader view 
of  the significance and impact of  these effects in vivo.  We also comment on the 
droplet-endothelial interaction that may facilitate these effects.  Currently, bioeffects 
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associated with ADV and the endothelium have not been reported yet, thus this 
dissertation is aimed to fill this void.     
The dissertation is organized into five chapters.  Chapter 2 presents the first 
findings on the effects of  vaporizing droplets on a cell monolayer of  ECs using a 
focused, single-element 3.5 MHz.  In this chapter we present the bubble cloud 
(generated as a result of  ADV) as a function of  pressure and pulse length while 
observing and quantifying cell detachment and cell viability.  Chapter 3 discusses 
these bioeffects when using a 7.5 MHz transducer and makes a comparison to those 
obtained when insonating at 3.5 MHz providing explanations to possible 
frequency-dependent mechanisms of  cell injury.  Chapter 4 investigates vaporization 
confinement and proximity effects.  This chapter shows how the effects seen in the 
previous chapters are lessened or amplified by localizing vaporization away from the 
cell monolayer in open or confined environments.  Finally, chapter 5 summarizes 
our findings and makes appropriate conclusions based on our evidence, while chapter 
6 discusses some of  the limitations of  our studies and provides ideas for future 
experiments.  It is the intention of  this dissertation to build a platform for 
subsequent studies that are capable of  filling the remaining voids in the quest for a 







Figure 1.1: An illustration of  gas embolotherapy.  Droplets circulate freely through 
the bloodstream until the target is detected.  Acoustic droplet vaporization using a 
highly focused ultrasound turns the microdroplets to gas bubbles that will eventually 















Figure 1.2: Anatomy of  a blood vessel showing the location of  the endothelium 














Figure 1.3: ADV applications in drug delivery and cancer therapies. In addition to 
occlusion of  vessels, leaky endothelium in tumors may allow droplets to enter and 
accumulate in the intersituim allowing for highly localized drug delivery to cancerous 
cells.(top).  Bubbles formed through ADV and subsequent interaction with US may 
increase endothelial wall permeabilization and induce upregulation or 
















Figure 1.4: Progression of  an artery with endothelial dysfunction.  The first lesion 
occurring during the first decade will develop into a major lesion that could lead to 





Characterization of ADV-induced 
bioeffects on endothelial cells using a 




ADV is capable of  transforming DDFP microdroplets into bubbles that are up to 150 
times – in volume – larger than the original droplet size [8].  This dramatic change 
in size will provide enough volume for occlusion of  small blood vessels supplying 
tumors, but could also lead to significant cell injury due to the generation of  high 
pressures and shear stresses during bubble expansion [8, 10, 12, 13, 44, 45].  Bubble 
expansion resulting from ADV inside tubes was previously investigated by our group, 
but it was not until recently that effects of  initial droplet size along with the liquid 
consumption phase and bubble evolution was further investigated in a series of  
studies [44, 45].  These new studies presented a theoretical [44] and computational 
[45] model that described the evolution of  a droplet undergoing ADV inside a rigid 
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tube, from the liquid consumption (phase transition) to bubble expansion and whose 
initial conditions were empirically obtained.  The results showed the existence of  a 
critical droplet size below which the bubble evolution is highly oscillatory, whereas a 
damped evolution is observed otherwise.  These differences in bubble evolution 
represent oscillations driven by viscous dampening inside a tube sufficiently large 
when compared to the initial droplet diameter.  Three bubble growth regimes with 
particularly high pressures in the early stage of  bubble evolution were also observed.  
With these new studies, shear stresses were found to be dependent on the initial 
droplet size, but were significantly lowered (by five orders of  magnitude) when 
compared to those previously reported in earlier studies [12, 13].  Nonetheless, 
calculated pressures were still far above those found physiologically.    
As thousands of  these microdroplets of  various sizes circulate the bloodstream 
spanning the entire cross section of  a blood vessel it will be possible for multiple 
vaporization events to occur at or near the vessel wall (Figure 2.1).  The relative size 
of  the US beam when compared to the diameter of  the blood vessel under treatment 
will likely determine the extent of  the damage, making smaller vessels (relative to the 
beam width) more susceptible to events near the vessel wall.  Not only will these 
vaporization events be important, but also the rapid oscillations of  the subsequently 
formed bubbles if  the US remains on after vaporization has been completed [46, 47, 
48, 49, 50].   
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Droplet concentration, bubble evolution (dependent on droplet size), relative 
location inside the blood vessel and also the selection of  acoustic parameters could 
determine the range of  bioeffects associated with ADV and consequently their 
clinical relevance and potential application.  The high probability of  these events 
due to droplet concentration in conjunction with high pressures and shear stresses 
generated during vaporization and bubble expansion could translate to a higher risk 
of  denuding or affecting the endothelium, for example.  However, if  under control 
these effects could aid in a number of  applications, such as cellular permeability and 
localized thrombosis for therapy.   
This chapter focuses on ADV events close to a vessel wall and using a 3.5 MHz 
transducer.  Other parameters like peak negative pressure (PNP) and pulse length 
are varied, while droplet concentration is held constant.  With this study we intend 
to provide the first insights in bioeffects of  ADV on endothelial cells.  It is of  
particular interest to characterize the direct effects of  ADV while finding those 
acoustic parameters that would allow us to perform significant ADV with minimal 
damage to the endothelium as well as understanding the underlying mechanism of  
cellular injury.     
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2.2 Materials and Methods 
2.2.1 Cell Culture  
Primary human umbilical vein endothelial cells (HUVEC) were cultured and 
supplemented with EGM-2 cell media (Lonza Clonetics™; Walkersville, MD).  
These cells were incubated at 37ºC in a humidified environment and 5% CO2.  Cells 
were grown in culture flasks for one passage and then transferred to OptiCell™ 
culture chambers (Nalgene Nunc International; Rochester, NY) previously coated 
with fibronectin (Ca. No. 354008, BD Biosciences; San Diego, CA) prior to US 
experiments.  The cells were grown to ~90% confluence and only passages one 
through four were used in these experiments. 
2.2.2 Droplets  
Albumin-coated droplets with a DDFP core were obtained from the Department of  
Radiology at the University of  Michigan, Ann Arbor.  The droplet solution was 
made following a procedure described elsewhere [8].  Briefly, droplets were made by 
combining 750 µL of  4 mg/mL (BSA) bovine serum albumin (Sigma Aldrich, St 
Louis, MO), dissolved in normal saline (0.9% w/v, Hospira Inc., Lake Forest, IL), 
and 250 µL of  perfluoropentane (C5F12, CAS Number 678-26-2), Strem Chemicals, 
Inc., Newburyport, MA).  While in an ice bath the two phases were emulsified via 
sonication using a tapered microtip accessory (model 450, 20 kHz, 3.2 mm diameter, 
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Branson Ultrasonics, Danbury, CT) operating at 125 W/cm2 for 30 seconds in 
continuous mode.     
2.2.3 Ultrasound Setup  
A schematic of  the setup is provided in Figure 2.2.  All experiments were conducted 
in a tank containing degassed, deionized water maintained at 37ºC.  The tank was 
made from acrylic with a polystyrene window at the bottom to provide a clearer view 
when looking through the microscope.  Six pegs located around the polystyrene 
window were used to slide an OptiCell™ chamber and hold it in place.  The tank 
was placed on top of  an inverted microscope (Nikon Eclipse TE2000-S, Nikon 
Instruments, Inc., USA) to observe and record the ADV event and for fluorescence 
microscopy.  A single-element 3.5-MHz (A381S, 1.9 cm-diameter, 3.81 cm-focal 
length, Olympus Panametrics-NDT, Waltham, MA) transducer was focused at a 40º 
angle to the bottom membrane of  an OptiCell™ chamber located at the bottom of  
the tank.  The transducer was calibrated using an in house designed fiber-optic 
probe hydrophone [51].  Data on the axial and cross sectional beam profiles as well 
as pressure at the focus were obtained ().  The transducer was placed at an angle to 
minimize standing waves from the bottom of  the tank.  A “dummy” OptiCell™ 
(upper membrane cut out) was used for the alignment of  the transducer.  The US 
pulses were generated using two function generators.  A primary function generator 
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(HP-3314, Hewlett Packard) was used to produce a signal while a secondary function 
generator (33120A, Agilent Technologies; Palo Alto, CA) was used as a gate.  The 
output signal was then amplified using a power amplifier (-60 dB, GA 2500A, Ritec 
Inc.; Warwick, RI) whose output was connected to the single-element transducer.  
An omnidirectional hydrophone (ITC-1089D, International Transducer Co.; Santa 
Barbara, CA) was also used to record acoustic noise.  All the signals were 
monitored using an oscilloscope (WaveSurfer 44Mxs, LeCroy; Chestnut Ridge, NY).  
2.2.4 Exposure Protocol 
The cell media was replaced with fresh, warm (37ºC) media prior to the experiments.   
A volume of  100 microliters of  a solution containing 108 droplets per milliliter was 
added to the 10-mililiter cell culture chamber to produce a final concentration of  106 
droplets per milliliter.  This concentration yielded and approximate 10:1 droplet to 
cell ratio.  The OptiCell™ was gently tilted side to side to evenly distribute the 
droplets over the cell monolayer.  The OptiCell™ was then submerged inside the 
tank and left for 2 minutes to equilibrate and for the droplets to settle to the bottom 
of  the chamber.  One OptiCell™ chamber was divided into a grid that consisted of  
13 rows and 9 columns.  This accounted for 13 different experimental groups and at 
most, 9 different replicates.  These 13 experimental groups contained all 
combinations of  pressure and pulse length including a treatment with zero (0 MPa) 
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pressure.  A second OptiCell™ chamber was used and divided in the same way to 
perform a control experiment that included the same treatments, but without droplets.  
Both OptiCells™ were seeded using the same cell density and kept until they reached 
~90% confluence.  A motorized stage (Proscan II, Prior Scientific; Rockland, MA) 
mounted onto the inverted microscope was used to move the tank along with the 
OptiCell™ to the specific area for treatment.  The transducer was moved away from 
previously formed bubble clouds to avoid any shadowing effects.  PNPs ranged from 
0 to 8 MPa, while pulse length was varied by changing the number of  cycles to 4, 8 or 
16.  The number of  cycles was the input number into the system and were used as 
the nominal value, however due to the ring-up/ring-down artifacts, the actual number 
of  cycles was 3, 7 and 15, respectively (see Apendix D).  These corresponded to 
pulse durations of  0.86 µs, 2 µs and 4.29 µs, respectively.  The upper limit of  the 
pressure range selected corresponded to the saturation pressure of  the transducer, 
while the cycles corresponded to a range that has been previously used in our lab for 
in vivo experiments [52].  The ADV events (i.e. bubble clouds) were recorded using a 
camera (CoolSNAP ES, Roper Scientific Photometrics; Tucson, AZ) mounted into 
the inverted microscope and MetaMorph Premier (Molecular Devices, Sunnyvale, 
CA).  Upon completion of  the treatments, the chambers were immediately taken 
out of  the tank for fluorescence staining. 
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2.2.5 Fluorescence Microscopy  
The cell media was carefully withdrawn from the culture chambers using a 10 
milliliter syringe.  The cell culture was rinsed 2x with phosphate buffered saline 
(PBS) containing 2% bovine serum albumin (BSA) to remove any excess droplet 
solution.  One milliliter of  a solution containing nucleic acid stain Hoechst 33342 
(Ca. No. H3570, Molecular Probes®, Life Technologies™, Carlsbad, CA) and 
ethidium homodimer-1 (Ca. No. L-3224 (component B) Molecular Probes®, Life 
Technologies™, Carlsbad, CA) was added to the culture chamber and supplemented 
with 9 milliliters of  culture media to a final concentration of  3 µM.  OptiCells™ 
were incubated for 30 minutes at 37ºC in the dark.  Following incubation the 
staining solution was withdrawn; the OptiCells™ were rinsed with PBS and fixed in 
4% paraformaldehyde for 15 minutes.  After fixation, the OptiCells™ were rinsed 2x 
and stored in HEPES (with sodium azide) at 8ºC.   
Each area exposed to an ADV event was examined using a 4x magnification 
objective (Plan Fluor, Nikon; Melville, MA).  A fluorescence image consisting of  a 
Hoechst stained (total cell count) and an EthD-1 stained (dead cell count) frame was 
obtained for each area and recorded using MetaMorph 7.5 (Molecular Devices, 
Sunnyvale, CA).  In a different experiment, a 2 µM solution of  calcein AM (Ca. No. 
L-3224 (component A) Molecular Probes®, Life Technologies™, Carlsbad, CA) was 
used to stain the cytoplasm of  the cells (green fluorescence).  
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2.2.6 Image Processing  
The collected images were post processed using Adobe Photoshop CS5.1 (Adobe 
Systems Inc., San Jose, CA) to create overlays.  Individual frames of  cells were 
transferred to ImageJ (U. S. National Institutes of  Health, Bethesda, Maryland) for 
image processing that included conversion to binary (black and white) and particle 
count using the “Analyze Particles” tool to determine the total number of  cells and 
the number of  dead cells per frame.   
2.2.7 Statistics  
Each treatment consisted of  between 6 and 9 replicates. R (The R Project for 
Statistical Computing) and Minitab 16 (Minitab Inc., State College, PA) were used to 
carry out the statistical analysis.  Statistical significance of  effects was assessed by 
performing a general linear model (GLM) analysis as well as a Dunnet’s test to 
compare experimental groups to our control.  P-values below 0.05 were considered 
statistically significant throughout the experiments. 
2.3 Results 
Each spot in the culture chamber was exposed to only one pressure and pulse length 
combination.  All treatments were randomly selected inside the chamber to 
minimize uncontrollable sources of  error like differences in cell density.  
Comparisons between the control and experimental groups were used to identify the 
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effects caused by ADV including those caused by either US alone or droplets alone.  
As we mentioned in section 2.2.4, the control group consisted of  all the pressure and 
pulse length combinations without the addition of  droplets, while the experimental 
group consisted of  all the combinations with the addition of  droplets and thus 
provided the elements necessary for ADV.  It has been previously shown that ADV 
is a threshold phenomenon [8] , and as such it only happened when the PNP was 
above said threshold (~4 MPa).  This threshold was optically obtained by observing 
consistent vaporization (production of  bubbles) as the acoustic pressure and pulse 
length was increased.  DDFP droplets have minimal acoustic scattering compared 
to gas bubbles so those treatments below the threshold served to investigate the effect 
of  droplets alone.     
2.3.1 Bubble cloud and localized damage  
Once above threshold, the size of  the bubble cloud generated by ADV increased with 
pressure, but was not affected by the pulse length (Figure 2.3 and Figure 2.4).  
Preliminary experiments showed damaged areas as stained with fluorescent dye 
calcein AM and EthD-1 after ADV was performed.  These areas were inspected and 
overlaid using the corresponding bubble clouds to evaluate the localization of  the 
damage.  Qualitative observations of  these images showed that the impact of  ADV 
was highly localized as damage zones corresponded to an area that was almost equal 
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in size to that of  the bubble cloud (Figure 2.5).  In addition, viable cells were 
observed inside the damage (vaporization) area.          
2.3.2 Cell attachment  
The total number of  cells from each spot was used to determine differences in cell 
density within and between culture chambers.  This number not only helped 
determine initial cell density, but also the number of  cells that could have been 
sheared-off  during ADV (Figure 2.6), and as a consequence, washed away from the 
chamber during rinsing steps.  This was carried out for both the control and the 
experimental culture chambers.  The total number of  cells between treatments in the 
control group, which included all treatments without droplets, was not significantly 
different.  Forty five untreated spots were randomly selected in the experimental 
chamber to account for cell density.  These were not significantly different when 
compared to our control chamber.  This result showed that the same order of  cell 
density was found in both chambers.   
According to the statistical analysis, pressure was a significant factor, but a 
change in pulse length (number of  input cycles) was not significant.  However, a 
two-way interaction effect was also found significant.  Major and significant 
differences were found when the pressure-pulse length combination was greater or 
equal to 6 MPa and 4 cycles (Figure 2.7).  These pressures were responsible for the 
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generation of  larger bubble clouds and as a consequence, larger affected areas.  
Significant differences in the total number of  cells when compared to our control 
(100%) ranged from an average of  20% to 47% cell reduction when the pressure-pulse 
length combination was increased from 6 MPa and 4 cycles to 8 MPa and 8 cycles, 
respectively.  For those treated with pressures below the ADV threshold (pressures 
under 4 MPa) there were no significant differences when compared to the control 
group.   
2.3.3 Cell Death  
The number of  dead cells was also obtained for both the control and experimental 
groups.  No significant differences were found across treatments in the control 
group.  Cell death was approximately 1% of  the total cell count.  In the 
experimental group pressure was found to be a significant factor, whereas cycles were 
not.  However, an interaction effect was found to be significant as well.  Cell death 
was no higher than 5% of  the total cell count in the experimental group, but was 
found to be significantly different when compared to the control group at a 
pressure-pulse length combination of  6 MPa – 8 cycles or higher (Figure 2.8).       
2.3.4 Additional Experiments  
Another experiment was carried out following the procedure aforementioned having 
pressure as the only dependent variable with increments of  1 MPa.  Pulse length 
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was not a significant factor in the previous experiment (Figure 2.9) and as such was 
kept constant at 8 cycles. Cell attachment and viability was not significantly affected 
in the control group.  A pressure greater or equal to 6 MPa was found to be 
significant for the experimental group (Figure 2.10).  Cell death was still kept at 
near 1% of  the total cell count for the control group and between 2% and 5% for the 
experimental group (Figure 2.11).  However, cell death was significantly different 
between the control and experimental group for all treatments.    
2.5 Discussion 
The present study shows the effects of  ADV on an EC monolayer.  To the best of  
our knowledge this is the first study that shows the ADV-endothelial interaction 
under acoustic conditions relevant to GE.  The main findings of  this work are the 
dependency of  bubble cloud area (BCA) and cell attachment to PNP at a given 
frequency and droplet concentration.  Both BCA and cell detachment increase with 
increasing PNP.  The increase in BCA can be explained by the shape of  the US 
beam and the area fraction above threshold and its direct relationship to pressure.  A 
maximum area, limited by the saturation limit of  the transducer, will be reached even 
if  the transducer is driven at higher pressures.  Consequently, this increase in BCA 
can explain the increase in cell detachment as more droplets were included (and 
vaporized) under the beam area as the pressure was increased.  Interestingly, cell 
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death did not behave as such.  Cell death was found to be significant only above a 
certain pressure-pulse length combination indicating that a threshold phenomenon 
may be responsible for this effect.  However, a second experiment did not support 
this hypothesis as cell death was significantly different across all treatments 
containing droplets when compared to the control group.  This discrepancy may be 
due to inherent differences between cell populations coming from different donors.   
Another important finding of  this work is the lack of  an effect due to pulse 
length for bubble cloud formation.  In theory, one effective cycle (from amplifier to 
transducer) above threshold should be sufficient to trigger vaporization, while 
subsequent cycles of  the pulse would be responsible for driving the previously formed 
bubbles.  Hence, the lack of  dependency on this parameter was no surprise.  Other 
studies [53, 54] have shown similar trends in which pulse length had no effect on the 
ADV threshold, especially for pulse lengths under 1000 µs.  However, these studies 
did not address the size of  the bubble cloud.  Bubble cloud size was considered by 
other studies [55, 56] and found to be dependent on pulse length; however these 
results were based on cavitating bubble clouds generated by histotripsy pulses (PNP > 
21 MPa).  The pulses used in the present study were kept under 5 µs with PNPs not 
exceeding 8 MPa.   
If  a bubble is formed with one cycle, then cell damage may be affected by pulse 
length as cells will be exposed other mechanical events aside ADV, as for example, 
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bubble oscillations.  Interestingly, cell damage (detachment and death) was not 
affected by pulse length.  An explanation for these results may be that cell injury 
happens during the first cycle(s) of  the US pulse when the bubble cloud is initially 
created or during the phase transition stage.  This event may be so violent that cells 
are killed and sheared off  almost immediately from the insonated area and as a result, 
subsequent bubble oscillations occurring in a depleted area will have no effect.   
A two-way interaction effect was found to be significant between pulse lengths 
and PNP.  The relevance of  these interaction effects falls under the definition of  
non-additive effects.  In other words, a change in one variable (e.g. pulse length) 
does not yield a proportional (additive) effect in the response (total cell fraction) 
when a second variable (PNP) is kept constant, but rather it may subdue or amplify 
such effects.  For example, pulse length was doubled each time, but the total number 
of  dead or detached cells did not respond proportionally.  Notion of  this interaction 
effect may confirm that it is in fact a portion of  the US pulse responsible for the 
observed damage as this did not respond proportionally to an increase in the pulse 
length.  In other words, the first couple of  cycles of  the US pulse (and not the whole 
pulse) were responsible for most of  the damage.  Addition to more cycles should 
have translated to more damage proportionally had this not shown an interaction 
effect.   
No depletion or significant cell death was observed in any of  the controls 
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indicating that it is indeed, an US-droplet and/or US-bubble interaction, the cause of  
significant bioeffects.  Phase transition, bubble formation and subsequent expansion 
may have been responsible for injuring, killing or weakening the anchor created 
between the cells and the fibronectin coating the culture chamber, and as such cells 
were released and lost as fluid was withdrawn and replaced from the chamber during 
rinsing steps.  In addition, droplets may have been directly attached to the cell 
surface breaking off  the cell membrane at the time of  vaporization.  In the results 
from experiments as the ones observed in Figure 2.5 the number of  dead cells is 
appreciable for a pressure of  4.5 MPa, while those affected by a pressure of  4 MPa in 
a second experiment, where significantly less.  These discrepancies in dead cells are 
attributed to the differences in staining protocols for both experiments, in which it 
was necessary to perform more rinses in the second experiment when compared to 
the first possibly removing more “floating” or weakly attached injured cells. 
Shear forces created with the syringe during fluid replacement were thought to be 
important, but only near the inlet or outlet ports.  Special care was taken when 
injecting and withdrawing fluid to avoid any cell detachment.  The success of  this 
technique was evaluated by observing the cell attachment and viability in the control 
group chamber, where differences in cell count in a number of  spots including those 
near the inlet ports were non-significant.  Cell detachment was also reported in an 
earlier study [27] in which Chinese hamster ovarian (CHO) cells were exposed to 
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ADV for the delivery of  a chemotherapy agent using dual phase microdroplets.  Cell 
detachment was thought to be caused by high velocities generated by a rapid liquid 
consumption and bubble expansion process or IC during ADV, which in turn could 
potentially induce high pressures and shear stresses during the collapse phase.   
The area depleted of  cells was optically compared to the bubble cloud area 
generated during ADV by overlaying both images. It was observed that the affected 
area was less than or equal to the bubble cloud area.  This matching of  areas is 
another important finding of  this work because it demonstrates that the cell damage 
is limited by the size of  the bubble cloud as it is implied by the absence of  detached 
or dead cells beyond the bubble cloud area emphasizing the concept of  localized 
damage.  This result hints yet another explanation of  the mechanism of  cell injury 
in which the droplet’s albumin shell may play an important role.  The EC surface 
contains a number of  albumin-binding proteins that have been described previously 
and are believed to induce endocytosis [57, 58, 59].  Hence, it is plausible to state 
that the albumin shell covering the surface of  the droplets may have stimulated an 
endocytosis pathway leading to attachment or partial transport of  some droplets 
inside the ECs putting these at risk of  direct ADV events capable of  affecting vital 
organelles and the cell membrane.   
Cell death was evaluated by the uptake of  ethidium homodimer-1 (EthD-1), a 
cell-impermeant nucleic acid stain that produces a bright red fluorescence on 
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damaged or dead cells.  Cell death is a naturally occurring phenomenon mediated 
either by a necrotic or apoptotic pathway, so the presence of  dead cells in our 
controls was normal.  Therefore, a normalized dead cell count was used to estimate 
the percentage of  cells affected by ADV.  This was achieved by obtaining the ratio of  
the number of  dead cells for each experimental case over that of  our control.  Dead 
cell fractions were found to be significantly different from our control when the 
pressure-pulse length combination was 6 MPa and 8 cycles or higher, but kept below 
5%.  However, on a second experiment cell death was found to be significantly 
different from our control for all treatments going from an average dead cell 
percentage of  1% to 4%.  Although, this dead cell percentage was still maintained at 
or below 5%, we believe that a phenomenon described by a rolling “sticky ball” may 
have been partially responsible for this increase in cell death.  This mechanism 
involves droplets (sticky balls) rolling down the cell monolayer (mainly during the 
removal of  these from the culture chamber), constantly sticking and detaching from 
the cells possibly breaking off  the cell membrane.   
Error in the measurement of  the dead cell count, quantified as one standard 
deviation from our mean for each case was rather high for all treatments containing 
droplets.  This observation led us to comment on another event capable of  causing 
an increase in cell death.  As mentioned earlier, ADV and IC are both threshold 
phenomena, but it was shown in an earlier study that IC is also a probabilistic event 
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[53].  Thus, cell injury during ADV may be attributed to permanent factors such as 
rapid liquid consumption and bubble expansion, but also to probabilistic events such 
as IC.  Therefore small error bars should be found at pressures where IC is very 
unlikely or very likely to happen (low and high pressures respectively).  Conversely, 
higher error should be present at mid-range pressures where IC is equally bound to 
occur or not.  Unfortunately, our data showed no evidence of  this, as there was high 
error for all treatments.            
In the vasculature, EC sense shear stresses and other mechanical stimuli and 
through mechanotransduction can change their morphology as well as alter 
important intra or intercellular signaling cascades to meet metabolic needs and the 
overall body homeostasis [38].  Some examples of  altered endothelial functions 
include the upregulation of  growth factors, cytoskeletal reorganization and increased 
permeability.  However, if  these stresses are increased (or decreased) beyond 
physiological conditions EC functions could be impaired resulting in endothelial 
dysfunction or death [23].  From a physiological perspective, impairment of  
endothelial functions could be of  great concern and even pathological if  they are not 
identified promptly and controlled [38].  Risks of  thrombus formation, fat 
accumulation, and atherosclerosis are major consequences of  endothelial dysfunction 
to name a few.  However, it is pertinent to point out that loss of  normal endothelial 
functions will not necessarily translate to undesired effects.  As a cancer treatment, 
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gas embolotherapy could potentially benefit from some of  these effects providing yet 
additional mechanisms to aid in the eradication of  the cancerous tissue, which is the 
ultimate goal of  any cancer therapy.  Damage to the endothelium could induce 
thrombosis at the site of  vaporization providing additional occlusion to those affected 
vessels.  Controlled impairment of  endothelial functions like permeability could 
also aid in the delivery of  drugs or other substances that will need to cross the 
endothelial barrier during treatments.  Several studies [20, 22, 28] have confirmed 
this by showing an increase in the uptake of  different molecular species when 
endothelial cells were exposed to US in the presence of  contrast agents, but more 
importantly, ADV was also proved to provide similar effects in cell permeability [27].  
In other words, if  controlled, not only will ADV provide an embolus to a specific 
location in the vasculature, but will also provide a mechanism for triggering local 
drug delivery following occlusion given that cell viability can be sustained.       
It is imperative to emphasize to the reader that the aforementioned results were 
obtained in a controlled in vitro experiment and that in vivo situations are difficult to 
mimic.  An idealized monolayer of  endothelial cells (HUVEC) supported by 
fibronectin was used when in actuality the endothelium is supported by an 
extracellular matrix composed of  a mesh of  different molecular components and 
other different layers of  cells with different mechanical properties.  HUVECs are 
commonly used cells in this field; however it is worth mentioning that the cellular 
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response endothelial cells in general may vary depending on their origin as well as 
their initial pathological state in the vascular tree [39].  These experiments only 
accounted for damage to the endothelium when ADV happened in close proximity to 
the cell monolayer and probably represent a worst case scenario that may occur 
during treatment, but how this damage changes with distance away from the 
monolayer is still unknown, but a work in progress.  Other parameters like droplet 
to cell ratio and droplet size are believed to affect the degree of  damage and should 
also be studied.  Longer pulses or the inclusion of  pulse repetition frequency (PRF) 
may be needed in clinical practice to increase the number of  vaporized droplets in the 












Figure 2.1: Droplets of  various sizes flow inside the blood vessel (1) until an 
ultrasound beam triggers ADV that may occur near or at the vessel wall (2) impacting 
endothelial cells and ultimately important vessel functions (3).  Note: droplet in (2) 








Figure 2.2: Ultrasound setup.  A single element transducer is placed at an angle 
focused at the bottom of  an OptiCell™ culture chamber.  ADV events are recorded 


















Figure 2.3: Bubble clouds as generated during ADV at 4 MPa (left column), 6 MPa 
(middle) and 8 MPa (right column).  Rows represent number of  cycles as follows: 4 
(upper), 8 (middle) and 16 (bottom).  The US beam travels from NE to SW (arrow).  















Figure 2.4: Bubble cloud area versus pulse length.  Vaporization (ADV) threshold is 
at 4 MPa, 4 cycles.  Error bars correspond to one standard deviation (n=8).  





















Figure 2.5: Endothelial cells stained with fluorescent dye calcein (live cells) and 
EthD-1 (dead cells) after ADV at 3.5 MPa (left column) and 4.5 MPa (right column).  
By creating an overlay of  the images containing the bubble clouds (bottom row) 
generated during ADV we can see that the damage zones are practically the size of  
said bubble cloud.  Note that a few cells inside this damage zones have survived 



























Figure 2.6: Representative images depicting cell damage after ADV compared to a 
control (top left).  Cell death (red stain) as well as sheared off  cells (empty spaces in 
the center) increase with pressure: 4MPa (top right), 6 MPa (bottom left) and 8 MPa 
(bottom right).  The ultrasound pulse consisted of  8 cycles.  Cells were stained with 













Figure 2.7: Total cell fraction as normalized by our control.  The total cell fraction 
corresponds to the total number of  cells in each treatment divided by the total 
number of  cells in our control (0 MPa, 0 cyles, no droplets).  Each treatment is 
described by a peak-negative pressure (MPa) and a number of  cycles.  Vaporization 
(ADV) threshold is at 4 MPa, 4 cycles.  Asterisks (*) denote treatments that are 
significantly different from the control (p<0.05).  Error bars correspond to one 














Figure 2.8: Dead cell fraction as normalized by our control.  The dead cell fraction 
corresponds to the total number of  dead cells in each treatment divided by the total 
number of  cells in our control (0 MPa, 0 cyles, no droplets).  Each treatment is 
described by a peak-negative pressure (MPa) and a number of  cycles.  Vaporization 
(ADV) threshold is at 4 MPa.  Asterisks (*) denote treatments that are significantly 
different from the control (p<0.05).  Error bars correspond to one standard 













Figure 2.9: Total cell fraction as a function of  peak negative pressure for 4 cycles 
(blue diamonds), 8 cycles (red squares) and 16 cycles (green triangles).  Error bars 
correspond to one standard deviation (n=8).  No statistical significance (p<0.05) 


















Figure 2.10: Total cell fraction as a function of  peak negative pressure.  The total 
cell fraction corresponds to the total number of  cells in each treatment divided by the 
total number of  cells in our control (0 MPa, no droplets).  Red squares correspond 
to all treatments with droplets while blue diamonds correspond to treatments without 
droplets.  Vaporization (ADV) threshold is at 4 MPa.  Asterisks (*) denote 
treatments that are significantly different from the control (p<0.05).  Error bars 
















Figure 2.11: Dead cell fraction as a function of  peak negative pressure.  The dead 
cell fraction corresponds to the total number of  dead cells in each treatment divided 
by the total number of  cells in our control.  Red squares correspond to all treatments 
with droplets while blue diamonds correspond to treatments without droplets.  
Vaporization (ADV) threshold is at 4 MPa.  Significant differences (p<0.05) from 





Comparison of frequency-dependent 





Acoustic cavitation refers to events where previously formed cavities (gas bodies) 
expand and contract in the presence of  an acoustic field [60].  Two types of  
cavitation have been previously described and are referred to as stable and transient 
(inertial).  As mentioned in Chapter 2, stable cavitation happens when these gas 
bodies undergo small oscillations for many cycles of  the acoustic pressure.  If  the 
pressure is high enough, these gas bodies may collapse violently (Figure 3.1) due to 
inertial cavitation (IC) generating as a result, high temperatures and pressures 
capable of  inducing bioeffects on tissue [61]. 
A recent study demonstrated that changes in acoustic parameters could 
potentially establish the likelihood of  IC during ADV when insonating droplets at 3.5 
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MHz [53].  An important finding of  this work was the relationship between the 
thresholds for IC and ADV and the probability of  observing one event independently 
from the other.  According to that study, ADV could take place at pressures near 3 
MPa with almost zero chance of  IC.  In turn, IC was more probable to happen if  
pressures were greater than or equal to 5.7 MPa reaching an almost 100% chance of  
occurring if  pressures were greater than 8 MPa.  In addition, long pulse lengths 
were likely to lower the IC threshold, while keeping that of  ADV relatively constant.  
Other acoustic parameters had little effect on both thresholds as it was the case for 
PRF or were kept constant as it was the case for carrier frequency.  Carrier 
(transducer) frequency, though not investigated in that particular study, is also an 
important parameter that has been extensively studied in the diagnostic US field 
since it is known for significantly affecting the IC threshold as it is described by the 
mechanical index (MI) [15, 14, 61, 62].  The MI is an important metric in 
diagnostic US that predicts when significant bioeffects associated to transient 
cavitation are expected.  The MI is defined as the ratio of  the peak negative 
(rarefactional) pressure (PNP), which is derated for attenuation, and the square root 
of  the center frequency of  the ultrasound field and should not exceed a value of  1.9 
(per FDA regulations) in all but ophthalmic imaging where the limit is lower [63].  
The MI has also been associated with spatial peak-pulse average intensity (ISPPA) for 
which values above 1000 W/cm2 can be sufficient to induce transient cavitation [64].   
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For ADV, higher frequencies would be rather attractive as these will lower the 
ADV threshold making it easier to vaporize droplets, while being less likely to induce 
IC [53].  Unfortunately, the use of  higher frequencies for GE inside the body will be 
limited since these are not able to overcome tissue attenuation.  Therefore, the 
selection of  an appropriate carrier frequency for our application requires a more 
elaborate decision-making process.  This chapter explores this frequency-dependent 
phenomenon by comparing bioeffects generated during ADV at 3.5 MHz and 7.5 
MHz under the same conditions to elucidate the role of  carrier frequency in the 
generation of  significant bioeffects and the underlying mechanism. 
3.2 Materials and Methods 
All descriptions for materials and methods for this chapter follow those found in 
Chapter 2.  The following sections are briefly summarized for the benefit of  the 
reader.  For specific details of  materials or equipment used (i.e. manufacturer or 
catalog numbers), or other procedures please refer to Chapter 2, section 2.2.     
3.2.1 Cell Culture  
HUVECs were cultured and maintained at 37ºC in standard culture conditions.  
Cells were grown in culture flasks for one passage and then transferred to OptiCell™ 
culture chambers previously coated with fibronectin prior to US experiments.  The 
cells were grown to ~90% confluence and only passages one through four were used 
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in these experiments. 
3.2.2 Droplets  
Albumin-coated droplets with a DDFP core were obtained from the Department of  
Radiology at the University of  Michigan, Ann Arbor.   
3.2.3 Ultrasound Setup  
An acrylic tank containing degassed water was placed on top of  an inverted 
microscope to observe and record ADV events.  A single-element 7.5 MHz (A321S, 
1.9 cm-diameter, 3.81 cm-focal length, Olympus Panametrics-NDT, Waltham, MA) 
transducer was focused at a 40º angle to the bottom membrane of  an OptiCell™ 
chamber located at the bottom of  the tank.  The US pulses were generated and 
controlled using two function generators and an amplifier as described in Chapter 2, 
section 2.2.3 and monitored using an oscilloscope.  
3.2.4 Exposure Protocol 
Please refer to chapter 2, section 2.2.4 for details.  For this experiment PNPs ranged 
from 0 to 5 MPa, while pulse length was varied by changing the number of  cycles to 
a nominal value of  4, 8 and 16.  Contrary to the previously described transducer 
(3.5 MHz) in Chapter 2, the 7.5 MHz transducer reaches saturation close to 5 MPa.  
It is important to note that although the 3.5 MHz transducer was able to reach 
saturation much later (i.e. 8 MPa), the 7.5 MHz transducer is capable of  providing a 
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lower ADV threshold (2 MPa versus 4 MPa).       
3.2.5 Fluorescence Microscopy  
The OptiCells™ culture chambers were rinsed 2x with PBS containing 2% BSA to 
remove any excess droplet solution.  Cells were stained with nucleic acid dyes 
Hoechst and EthD-1 following the staining protocol, then fixed in 4% PFA and 
stored in HEPES with sodium azide to prevent fungal growth.  Each area exposed 
to an ADV event was examined using a 4x magnification objective.  A fluorescence 
image, consisting of  a blue (total cell count) and a red (dead cell count) frame, was 
obtained for each area and recorded using MetaMorph Premier software.  
3.2.6 Image Processing  
Fluorescence microscopy images were cropped using a Matlab (Mathworks, Natick, 
MA) script according to the beam width of  the new transducer in order to increase 
the signal-to-noise ratio of  each image.  These were transferred to ImageJ for image 
processing that included conversion to binary (black and white) and particle counting 
using the “Analyze Particles” tool to determine the total number of  cells and the 
number of  dead cells per frame.  Overlays were created using Adobe PhotoShop.   
3.2.7 Statistics  
Each treatment consisted of  between 6 and 9 replicates. This difference in sample 
size was due to imaging artifacts encountered during image acquisition.  Minitab 16 
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(Minitab Inc., State College, PA) was used to carry out the statistical analysis.  A 
general linear regression and an ANOVA were performed to determine significant 
factors affecting the response of  our experiments.  A Dunnet’s test was also used to 
compare experimental groups to our control.  P-values below 0.05 were considered 
statistically significant throughout the experiments. 
3.3 Results  
The results from this study are divided into three sections.  The first two will be 
focused on the results involving the 7.5 MHz transducer alone (sections 3.3.1 and 
3.3.2), while the second one will focus on making a comparison to those obtained in 
chapter 2, considering the change in carrier frequency (section 3.3.3).  Similar to 
chapter 2, this chapter shows the effects of  performing ADV using a single 7.5-MHz 
US pulse at various combinations of  PNPs and pulse lengths on ECs.  Damage was 
observed and assessed by the use of  nucleic acid stains Hoechst 33342 and ethidium 
homodimer-1 (EthD-1). 
3.3.1 Bubble Cloud 
The size of  the bubble cloud generated by ADV using a 7.5 MHz transducer was 
affected by each combination (above threshold) of  pressure and pulse length (Figure 
3.2).  A PNP of  2 MPa and 4 cycles was not able to provide sufficient energy to 
vaporize the droplets, but an increase to 8 cycles provided enough acoustic energy to 
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initiate ADV.  A general regression analysis was performed using the bubble cloud 
area (BCA) in mm2 as the response.  The variables Pressure and Cycles were used as 
predictors.  The variable Cycles was used as a categorical variable after a 
preliminary regression analysis revealed a lack-of-fit (p<0.05) for the initially 
proposed model.  This regression analysis yielded an equation for each Cycles 
group (Figure 3.3). 
According to this model, Pressure was a significant predictor, whereas Cycles 
was only a significant predictor for the treatment at 16 cycles, while Pressure*Cycles 
was a significant predictor for both the 8-cycle and the 16-cycle treatment when 
compared to the 4-cycle treatment.  Significant predictors are those variables that 
when included in a regression, significantly improve the prediction of  the response.  
The (adj) R-Sq of  this model was 92% with a non-significant lack-of-fit.  However, 
this model is only useful for predicting BCAs only at the three levels of  cycles tested, 
but for all values of  pressure between 2 and 8 MPa.   
3.3.2 Total Cell Fraction and Death Cell Fraction 
The total cell fraction (TCF) from each spot was used to determine differences in cell 
density across the culture chamber as it was shown in chapter 2.  An ANOVA of  the 
negative control group (chamber without droplets) and the treatments with droplets, 
but no ADV revealed that neither Pressure nor Cycles cause a significant change in 
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the mean and that the cell densities for both chambers were not significantly different.  
Therefore an average value of  the total cell count was used to normalize the data and 
obtain a TCF.    
  For the experimental group it was found that Pressure did not cause a 
significant change in the mean, however Cycles and an interaction between Pressure 
and Cycles were significant. A Dunnett’s test showed that only treatments with 
droplets 4, 16; 5, 8 and 5, 16 (pressure, cycles) were statistically different from our 
control (0, 0, no droplets).  Similarly, for the dead cell fraction (DCF), an ANOVA 
was performed.  However, a preliminary analysis of  the residuals revealed the need 
for a transformation of  the data.  The following analysis was performed using a 
power transformation (T) of  our data (T=Yλ) with lambda equal to 0.5 and Y equal 
to DCF.  According to the ANOVA none of  the variables used in our study affected 
significantly the value of  DCF^0.5. 
For the following section TCF was chosen over the DCF as a metric for 
bioeffects after our data indicated that the DCF did not seemed affected by a change 
in acoustic parameters (this chapter) or was maintained below 5% (Chapter 2).     
3.3.3 Frequency-dependent effects  
Chapter 2 showed how BCA could be predicted by only using pressure and how the 
pulse length (cycles) was not an important factor when vaporizing at 3.5 MHz.  In 
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this chapter however, it was observed that both pressure and cycles were significant 
variables affecting the value of  BCA.  To investigate this, the BCA data were plotted 
against the spatial peak-pulse average intensity (ISPPA) of  each treatment, which is a 
quantity that takes into account both pressure and pulse length [65].  By doing so, it 
was found that the intensities developed under the conditions tested by the 7.5 MHz 
transducer ranged from 60 to 200 W/cm2, while those from the 3.5 MHz transducer 
ranged from 150 to 1500 W/cm2.  This yielded two distinct curves, with both 
showing that BCA increased with increasing ISPPA.  
While ADV is a threshold phenomenon, both data sets were fitted using a 
sigmoid curve.  Fitting any other curve (e.g. linear, exponential) would result in less 
than ideal results as none of  these will appropriately describe the sub threshold 
region.  In addition, these curve fits will assume infinite BCA for infinite Isppa, a 
hypothesis that seems rather absurd and not supported by nonlinear acoustics which 
states that a saturation limit is expected [66].  Although there was no experimental 
data to validate the saturation region of  the sigmoid fit for the 7.5 MHz transducer, 
there is no reason to believe that this transducer will behave any differently than the 
3.5 MHz counterpart, which had data supporting our hypothesis.  In fact, a HIFU 
simulator developed by the FDA [67] was used to confirm (and estimate) the 
saturation limit.  This HIFU simulator integrates the axisymmetric KZK equations, 
which take into account the combined effects of  nonlinearity, beam diffraction, 
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interference and absorption.  Radial plots of  pressure and intensity were generated 
and used to determine the radius above threshold as the input power in watts was 
changed.     
This information provided enough evidence to confirm that in fact, the area 
available for vaporization offered by both transducers will saturate as the input power 
is increased (Figure 3.7) and that a sigmoid fit is indeed an appropriate choice.  In 
comparison to the 3.5 MHz transducer, the 7.5 MHz transducer showed a lower 
maximum area.  This result was no surprise since it is known that transducers of  the 
same focal length, but higher frequencies will saturate at lower intensities [66], 
therefore achieving smaller areas.  The sigmoidal fits yielded R-sq > 90%, which 
make the sigmoidal fit not only appropriate, but also an excellent predictor of  BCA.  
TCF data were also plotted against ISPPA for both frequencies (Figure 3.9).  It is 
worth reiterating that the TCF data was calculated taking into account the transducer 
beam width for both cases.  This was done in order to increase the signal-to-noise 
ratio of  the images used.  Both transducers showed a decrease in TCF as the ISPPA 
was increased within their respective ranges.  Significant damage occurred at an 
ISPPA of  near 200 W/cm
2 for the 7.5 MHz transducer and 1000 W/cm2 for the 3.5 
MHz transducer, which corresponded to a near 40% and 50% of  the maximum 
achievable areas (as estimated from the sigmoidal fits), respectively.   
The relationship for the 3.5 MHz transducer was slightly nonlinear (R-sq = 0.85), 
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while that of  the 7.5 MHz transducer was strongly nonlinear (R-sq = 0.56).  The 7.5 
MHz TCF data was fitted using sigmoid fit following an analogous reasoning as in 
the case for BCA.  In short, the TCF was unaffected or slightly affected by intensity 
until a significant value was reached, leading to a decrease in TCF.  It is expected 
that a minimum will be reached and be limited by the saturation area of  the 
transducer.  Although there are not data to support the second half  of  the sigmoid, 
this fit significantly improves the R-sq to a 0.7, explaining our data more accurately 
when compared to the linear fit.  The 3.5 MHz R-sq counterpart did not improve 
significantly when a sigmoid fit was used (0.87 versus 0.85), however we believe it is 
still the most appropriate model.   
To see how both transducers compare in their ability to vaporize and affect cells, 
a plot that included both the BCA (as a percent of  the maximum achievable area) 
and the TCF as a function of  ISPPA was generated (Figure 3.10).  Analogous to a 
pump performance and system curves, this plot lets us analyze operating conditions 
of  each transducer with their respective losses (TCF reduction).  An operating point 
defined as the intersection between both curves yielded a value of  68% for the 3.5 
MHz transducer and a 50% for the 7.5 MHz transducer corresponding to ISPPA values 
of  1150 W/cm2 and 215 W/cm2, respectively.  Operating below or above this point 
will sacrifice either vaporization area or cell viability (or attachment), respectively 
resulting in less than optimal results.          
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The TCF data was also plotted against the BCA taking into account differences 
in the transducers maximum achievable areas (Figure 3.11).  This was done by 
defining a normalized BCA as the ratio of  the experimental BCA and the maximum 
achievable area of  each transducer.  The plots revealed inverse relationships for both 
cases, with significantly different slopes.  More specifically, the 7.5 MHz transducer 
showed a slope equal to twice of  that for the 3.5 MHz transducer.   
3.4 Discussion 
The results presented here demonstrate the differences in the use of  a 3.5 MHz versus 
a 7.5 MHz transducer for ADV purposes.  To our knowledge this is the first study 
that describes these differences applicable to ADV and ultimately GE in terms of  the 
effects of  the cloud production on endothelial cells.  Firstly, it was shown that both 
pressure and pulse length had an important role in determining the BCA when using 
the 7.5 MHz transducer, while pressure was the only significant factor for the 3.5 
MHz transducer.  This discrepancy could be due in part to the relative contribution 
of  each parameter to the value of  intensity.  Under comparable transducer 
geometries, as higher frequency transducers are not capable of  meeting the pressures 
achieved by lower frequencies and can reach saturation faster, both pressure and time 
will have an equally important role in determining intensity.  In contrast, lower 
frequency transducers may rely mostly on their ability to generate higher pressures.  
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The data showed that BCA is strongly dependent in the intensity of  the transducer, 
making Isppa a better predictor than pressure and/or cycles under the conditions tested 
here. 
 Cell damage was described by a reduction in cells attached (TCF) after the 
quantity DCF showed a poor role in representing these bioeffects.  As vaporization 
was carried out cells were likely killed, sheared-off  and washed away after rinsing 
steps were performed removing any loosely attached or floating dead cells leading to 
DCFs of  less than 0.10.  This assumption comes in part from a number of  
computational studies stating that those stresses (more specifically, pressures) 
generated during an ADV event inside an idealized blood vessel will likely be several 
orders of  magnitude above those encountered physiologically.  For a given intensity, 
the 7.5 MHz transducer was more damaging than the 3.5 MHz transducer generating 
a lower TCF value by a factor of  2.  Intensities necessary to evoke transient 
cavitation are believed to be above 1000 W/cm2, and while significant damage occurs 
at this point for the 3.5 MHz transducer, this is not the case for the 7.5 MHz 
transducer.  A possible explanation for these effects is the fact that for higher 
frequencies the ADV threshold is lowered and vaporization of  smaller droplets, 
which do not make a significant contribution to BCA, are still capable of  directly 
affecting the cells.  This was previously documented in [8], where it was shown that 
two different droplet populations (in size) had the same threshold for a given 
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frequency.  Inertial or transient cavitation is also expected to occur when the MI is 
at or above 1.9.  However, only one of  the treatments included using the 7.5 MHz 
reached this critical value.  On the other hand, the presence of  IC events in the 
experiments including the 3.5 MHz transducer was not ruled out, as intensities 
greater than 1000 W/cm2 were achieved, and MI values reached and surpassed 1.9.  
Therefore, it is unlikely that IC had a significant role in generating these bioeffects 
when using a 7.5 MHz transducer, but these may correspond to a mechanical process 
linked to ADV.  
 As mentioned in chapter 2, ADV-related events leading to cell damage may 
include the rapid phase transition and bubble expansion processes.  These events 
may be responsible for evoking high shear stresses, pressures or other mechanical 
means for disrupting the cell integrity (i.e. cell membrane, attachment).  Extremely 
high pressures at the wall were estimated in a numerical study that simulated a 
bubble expansion inside a tube [45].  These pressures were developed in time scales 
O(0.5 µs), which corresponded to expansion velocities at their highest.  Although 
our experiments did not consider a tube, these time scales are so short that it may be 
plausible to expect a similar or higher pressure generation in our case, since 
vaporization happened at the wall.  In addition, IC bioeffects have been well 
documented in the past [61, 68, 69], which are believed to be caused mainly by either 
thermal or mechanical or even chemical means as it is the production of  highly 
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reactive chemicals capable of  affecting cells [69].   
Cell lysis is perhaps the most extensively studied bioeffect because of  the 
significant reduction in viability observed in most IC experiments [69].  Depleting a 
test sample of  most cells will make it almost impossible to quantify other effects 
induced by less harmful mechanisms associated with IC.  Nevertheless, if  cell 
viability is sustained other bioeffects may include changes in morphology, cell 
permeability and growth rate.   
We believe that the effects presented here are mainly attributed to ADV.  The 
close proximity of  the DDFP droplets to the cell monolayer makes the latter more 
susceptible to the direct effects from a vaporization event causing cell damage and 
eventually loss in cell attachment.  The results obtained from the 7.5 MHz 
transducer are in good agreement with this hypothesis as this transducer was not 
capable of  generating intensities or MI values above those reported for the onset of  
IC and yet induced greater effects when compared to the 3.5 MHz transducer.  
Nevertheless, IC could still be a possible explanation for other bubble-ultrasound 
related bioeffects, but predominantly after vaporization has taken place.  A possible 
explanation for this hypothesis is the fact that during ADV the bubble is at a high 
internal pressure (near 50 atm).  In addition, ADV (mainly the liquid consumption 
phase) may be over in less than 1 µs, thus bubbles of  resonant size may come out of  
resonance before significant pressures have time to act upon them.  If  cells are lysed 
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and detached during a vaporization event, there will be no cells present to account for 
bioeffects associated to IC.  The 7.5 MHz transducer has the ability to lower the 
ADV threshold while providing vaporization of  smaller droplets compared to the 3.5 
MHz transducer [8].  These smaller droplets, which may not significantly contribute 
to vaporization area, may still be responsible for the difference in bioeffects seen for 
both transducers.  As a result, the 7.5 MHz transducer experiences a relatively lower 




























Figure 3.1: Acoustic cavitation.  Bubbles endure several oscillations until a bubble 
grows in an unstable manner in the presence of  an acoustic field.  If  the acoustic 
pressure is sufficiently high these bubbles may collapse violently.  Peak positive 
pressures correspond to the compression phase, whereas peak negative pressures 

















Figure 3.2: Bubble clouds as generated during ADV at 3 MPa (upper row), 4 MPa 
(middle) and 5 MPa (bottom row).  Columns represent number of  cycles as follows: 
4 (left), 8 (middle) and 16 (right).  The US beam travels from NE to SW (arrow). 





















Figure 3.3: Bubble cloud area in mm2 for different pressure-cycle combinations using 
a 7.5 MHz transducer: 4 cycles (diamonds), 8 cycles (squares) and 16 cycles 
(triangles).  The ADV threshold is 2 MPa, 8 cycles.  The error bars correspond to 



























Figure 3.4: Representative images depicting cell damage after ADV using a 7.5 MHz 
transducer at 4 MPa, 16 cycles (left) and 5 MPa, 16 cycles (right).  Cells are stained 
with nucleic acid stain Hoechst, while dead cells are stained red with EthD-1. The 











Figure 3.5: Total cell fraction as normalized by our control.  The total cell fraction 
corresponds to the total number of  cells in each treatment divided by the total 
number of  cells in our control (0 MPa, 0 cyles, no droplets).  Each treatment is 
described by a peak-negative pressure (MPa) and a number of  cycles.  Vaporization 
(ADV) threshold is at 2 MPa, 8 cycles.  Asterisks (*) denote treatments that are 
significantly different from the control (p<0.05).  Error bars correspond to one 











Figure 3.6: Dead cell fraction as normalized by our control.  The dead cell fraction 
corresponds to the total number of  dead cells in each treatment divided by the total 
number of  cells in our control (0 MPa, 0 cyles, no droplets).  Each treatment is 
described by a peak-negative pressure (MPa) and a number of  cycles.  Vaporization 
(ADV) threshold is at 2 MPa, 8 cycles.  No significant difference was found between 





















Figure 3.7: The KZK model shows how a saturation point is reached for both 
transducers as the input power (W) to the transducer is increased.  The y-axis shows 






















Figure 3.8: Bubble cloud area (mm2) plotted against the spatial peak-pulse average 
intensity (Isppa) for the 3.5 MHz and 7.5 MHz transducers.  Both transducers show a 
sigmoidal behavior which is characteristic of  a threshold phenomenon reaching a 
saturation point.  The saturation point corresponds to the maximum achievable 
insonation area for each transducer as obtained using the FDA’s HIFU simulator.  
The sigmoid fit agrees favorably with the data as the R-sq for the 3.5 MHz and 7.5 
MHz fits are 0.99 and 0.91, respectively.  The insert on the top left takes a closer 













Figure 3.9: Total cell fraction (TCF) plotted against the spatial peak-pulse average 
intensity (Isppa) for the 3.5 MHz and 7.5 MHz transducers.  Both transducers show a 
decrease in cell fraction as the intensity is increased within their respective ranges.  
The behavior for the 3.5 MHz transducer is slightly nonlinear (R-sq = 0.85), while 
that of  the 7.5 MHz transducer is strongly nonlinear (R-sq = 0.56).  A TCF of  1 




      
 
 
Figure 3.10: The plot above presents the total cell fraction (TCF, triangles and 
diamonds) and a normalized bubble cloud area (NBCA, circles and stars) plotted 
against the spatial peak-pulse average intensity (Isppa) for each transducer.  Top plot 
corresponds to the 3.5 MHz transducer; bottom corresponds to the 7.5 MHz 
transducer.  The NBCA corresponds to the experimental BCA divided by the 
maximum achievable area obtained from the sigmoid fit of  the experimental data 












Figure 3.11: Total cell fraction (TCF) plotted against a normalized bubble cloud area 
(NBCA).  The BCA was normalized to account for each transducer maximum 




Vaporization proximity and 
confinement effects  
 
4.1 Introduction 
Chapters 2 and 3 focused their attention on characterizing the bioeffects of  ADV on 
ECs when varying different acoustic parameters.  This was however, presented as a 
worst case scenario since only droplets in direct contact with the monolayer were 
considered.  A direct inverse relationship between total cell fraction (TCF) and 
bubble cloud area (BCA) indicated that those events leading to bubble formation and 
further expansion were likely the cause of  cell injury.  We also presented evidence 
that suggested that the 7.5 MHz transducer will be more damaging (relative to its 
own beam width) when compared to the 3.5 MHz transducer probably due to its 
capability to lower the ADV threshold, hence vaporizing a greater number of  
droplets.   
While finding droplets in close proximity to the vessel wall (i.e. endothelium) is not 
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entirely improbable, factors such as droplet density and blood vessel size relative to 
beam size will be important in determining the extent and location of  damage.  For 
example, a beam whose width is similar to the diameter of  the targeted vessel will be 
able to provide vaporization at any point inside the vessel including those near the 
vessel wall (Figure 4.1(a)).  If  on the contrary, the beam width is smaller than the 
targeted vessel, vaporization – and as a result – damage could be localized to avoid 
(Figure 4.1(b)) or include (Figure 4.1(c)) the vessel wall, depending on the 
application.  In addition to the relative location of  the droplet inside the blood 
vessel, the relative size of  the droplet is also important.  As mentioned in the 
previous chapters, recent studies have investigated the role of  initial droplet size in 
the development of  pressures and shear stresses [12, 13, 45].  These computational 
studies determined that the generation of  stresses could change dramatically when 
going from rigid [12] to flexible [13] tube walls.   They also found that both peak 
shear stresses and peak pressures increase with increasing Rd/Rv [45], where Rd is the 
radius of  the droplet and Rv is the radius of  the vessel (tube).  Therefore, for a given 
droplet population, significant bioeffects may be generated in small blood vessels.   
These studies assumed vaporization in the center of  the tubes and neglected 
background flow.  The present study presents vaporization occurring in the wall 
opposite to the EC monolayer (Figure 4.2(b) and Figure 4.2(c)).  While it is 
understood that location of  vaporization may also play an important role the 
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generation of  shear stresses and pressures, containing droplets in the center of  
acoustically transparent tubes coated with ECs was a challenge.  We believe that 
although the absolute magnitude of  shear stresses and pressures will be altered by 
this idealized experimental setup, relevant trends related to bubble expansion and 
fluid inertia should still hold.  Significant pressures and shear stresses were found to 
occur at extremely short times O(0.5µs) regardless of  the droplet size.  Therefore, 
damage associated with ADV in our current setup can also be informative.  It is 
known that physiologically ECs are exposed to shear stresses in the range of  1-20 
dyne/cm2 with local increases – in certain areas of  the vasculature – between 30 and 
100 dyne/cm2 [70, 71, 72]. Therefore, significant deviations from these values would 
translate to major bioeffects that may include altered responses to physiological 
events or even cell detachment and lysis. 
The objective of  this chapter is to investigate how vaporization proximity as well as 
the relative level of  confinement of  vaporization affects ECs in a case-by-case basis. 
The level of  confinement will be assessed by changing Rd/Rv, while proximity will be 
explained by comparing these results to those obtained in chapters 2 and 3.  Both 
cases presented show vaporization away from the EC monolayer.  The first case 
presents vaporization with Rd/Rv = 0.01 (open environment), while the second case 
presents vaporization for Rd/Rv = 0.03 (confined environment).  For purposes of  
this study an open environment was defined as a situation where bubbles were 
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vaporized and fully expanded to its spherical shape in any direction, while a confined 
environment represented a situation where bubbles were only allowed to expand in 
one direction (Figure 4.2 and Figure 4.3).   
4.2 Materials and Methods     
4.2.1 Cell Culture  
HUVECs were cultured and maintained at 37ºC in standard culture conditions.  
Cells were grown in culture flasks for one passage and then transferred to OptiCell™ 
culture chambers previously coated with fibronectin prior to US experiments.  The 
cells were grown to ~90% confluence and only passages one through four were used 
in these experiments. 
4.2.2 Ultrasound Setup  
A similar setup to the one described in chapters 2 and 3 was used for these 
experiments.  Briefly, an acrylic tank containing degassed, warm (37ºC) water was 
placed on top of  an inverted microscope to observe and record ADV events.  A 
single-element 3.5 MHz (A381S, 1.9 cm-diameter, 3.81 cm-focal length, Olympus 
Panametrics-NDT, Waltham, MA) transducer was focused at a 40º angle to the 
bottom membrane of  an OptiCell™ chamber located at the bottom of  the tank.  US 
pulses were generated and controlled using two function generators and an amplifier 
as described in Chapter 2, section 2.2.3.   
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4.2.3 Exposure Protocol 
OptiCells™ are composed of  two flexible, 75 μm-thick polystyrene membranes 
separated by 2 mm.  The recommended maximum volume is 10 mL.  Withdrawal 
of  fluid beyond this point (< 10mL) would result in partial collapse of  the 
membranes, which is the basis for this experiment.  In the experimental group, two 
OptiCells™ were used to define two gap separations (300 and 100 µm approximately) 
that defined an open and a confined environment.  One OptiCell™ was used as a 
negative control.  In the experimental group ADV was carried out in those areas of  
the center of  the OptiCells™ were the gap separation was kept constant. The gap 
between the membranes was calculated as follows: total volume of  4 mL inside the 
OptiCell™ corresponding to a gap separation of  100 µm and 6 mL corresponding to 
300 µm.   The gap separation was verified by focusing the bottom and top 
membranes using the Z-direction motor of  the microscope and determining the 
change in focal distance.  A gap separation lower than 100 µm was particularly hard 
to achieve.  A gap distance of  200 µm was initially proposed, but the error in the 
measurement (±50 µm) did not allow for three mutually exclusive gap separations.  
These two gap separations (along with an average droplet radius of  1.5 µm) yielded 
an Rd/Rv value of  0.03 and 0.01, respectively.  ADV was generated using an 8-cycle 
pulse (3.3 µs) and 7 MPa of  acoustic pressure (peak rarefactional).  Images from the 
areas where ADV took place as well as other areas with no ADV were obtained to 
79 
 
account for the effects of  fluid withdrawal from the culture chamber.              
4.2.4 Fluorescence Microscopy  
The OptiCells™ culture chambers were rinsed 2x with PBS containing 2% BSA to 
remove any excess droplet solution.  Cells were stained with nucleic acid dye 
Hoechst following the staining protocol, then fixed in 4% PFA and stored in HEPES 
with sodium azide to prevent fungal growth.  Each area exposed to an ADV event 
was examined using a 4x magnification objective.  A fluorescence image consisting 
was obtained for each area and recorded using MetaMorph Premier software.  
4.2.5 Image Processing  
Fluorescence microscopy images were transferred to ImageJ for image processing 
that included conversion to binary (black and white) and particle counting using the 
“Analyze Particles” tool to determine the total number of  cells and the number of  
dead cells per frame.     
4.2.6 Statistics  
All cases studied consisted of  at least 10 replicates.  Minitab 16 was used to carry 
out the statistical analysis.  Statistical significance of  effects was assessed by 
performing a students’s t-test.  P-values below 0.05 were considered statistically 




4.3.1 Confinement  
As mentioned earlier in this chapter, confinement was described by the ability of  the 
bubble cloud to contacting the opposite wall of  the OptiCell™ chamber, where the 
ECs were attached.  A confined environment had an average Rd/Rv ratio of  0.03, 
while an open environment had an average value of  0.01.  This ratio was obtained 
using an average droplet radius of  1.5 µm, however higher ratios will exist 
throughout the chamber given the polydispersity of  the droplet distribution.   
 The results obtained from this experiment were presented in the form of  total cell 
fraction (TCF) as it was done in the previous chapters.  As this chapter only 
addresses the effects of  high pressures and shear stresses due to bubble expansion, 
cell detachment and not cell death was investigated.  Cell death was ruled a 
non-significant metric of  damage as it was revealed by the results of  chapters 2 and 3 
that it was kept at or below 5% with rather high standard deviations.  Figure 4.4 
shows representative images of  the overall effects of  performing ADV in either 
scenario.  As it can be seen in the figure, there is a significant reduction in cell 
density when ADV is performed in a confined environment.  Quantitative results 
are shown in Figure 4.5.   These results were normalized using our negative control, 
where cells were maintained in normal growth conditions with no US exposure or 
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droplet solution.  By doing so, the effects of  fluid withdrawal from the chamber 
were also taken into account.  These results showed that when compared to our 
negative control, fluid withdrawal had no effect in cell attachment in either case 
maintaining a TCF of  near 1.  Our experimental group showed that for the case 
where vaporization happened in an open environment (Rd/Rv = 0.01) cell 
detachment was not significantly different from our negative control.  However, 
when vaporization happened in a confined environment (Rd/Rv = 0.03), it led to 
significantly more damage, reducing the TCF to less than 0.1. 
4.3.2 Proximity  
This section utilizes the results obtained from the current study and compares them 
to those obtained in the previous chapters for similar conditions (Figure 4.6).  
Chapters 2 and 3 discussed the effects of  vaporizing droplets in direct contact to the 
EC monolayer.  This chapter showed results of  two cases where vaporization 
occurred away from the monolayer, but in environments that allowed bubbles to 
either expand in any direction or to be confined in one direction.  Figure 4.7 
summarizes these results as cases (a), (b) and (c).  These results indicated that all 
cases were statistically different from each other showing a greater damage for the 
case where ADV occurred in a confined space, namely 0.6, 1 and 0.1 TCF, 




ADV is a phenomenon that allows for local vaporization of  liquid droplets and 
subsequent embolism of  the gas bubbles.  Depending on the circumstances 
vaporization can occur far, near or even at the endothelial surface.  All of  these 
situations present different consequences in terms of  bioeffects induced to the vessel 
wall.  Vessel rupture and petechial hemorrhage has been observed in vivo by [52].  
The results presented here show a small portion of  all the possible bioeffects 
associated with shear stresses and pressures generated during vaporization.  
However, they provide the reader a better understanding of  how this process may 
affect ECs inside the blood vessels.  Studies carried out in [12, 13, 45] showed how 
shear stresses and pressures developed inside tubes for different initial droplet sizes 
and determined that peak shear stress increase with droplet size.  These peak shear 
stresses were found to be between 35 and 80 dyne/cm2 for droplet to tube ratios of  
0.078 and 0.144, respectively.  These shear stresses corresponded to conditions 
where fluid velocities inside the tube were at a maximum.  The same trend was 
observed here, although our ratios were well below those mentioned earlier.  A 
possible explanation for this is our inclusion of  hundreds of  droplets (bubbles) as 
opposed to the one modeled in these studies.  Multiple bubbles might have 
coalesced rapidly – matching their maximum expansion ratios – resulting in larger 
bubbles capable of  significantly increasing the fluid velocity inside the chamber.  
83 
 
This could have resulted in the generation of  shear stresses capable of  denuding the 
ECs from the membrane.  In the same manner, another explanation for the observed 
damages is the development of  high pressures during bubble expansion, which can 
reach up to 80,000 bar in 2 µs.  Shear stresses, on the other hand, will require longer 
times to develop due to the viscous resistance of  the fluid.  Thus, we believe that 
since these peak pressures occur at a much faster time scale than the peak shear 
stresses, they may be responsible for injuring cells or even rupturing the blood vessel 
before damages associated to shear stresses can be translated the endothelium.  
Shear stress will then be responsible for removing loosely attached dead cells 
explaining the reduced count of  these throughout our experiments.         
 Both proximity and confinement of  vaporization pose challenges that may not be 
easily controlled due to the polydispersity of  the droplet population.  
Monodispersity of  droplets could immensely aid in the prediction of  damages, but 
producing such a solution with the required sizes and quantity is rather difficult.  In 
addition, the ultimate goal of  the application will dictate which blood vessels will be 
targeted, putting small arterioles and capillaries at higher risk.  Therefore, reduced 
damage could be achieved if  vaporization is localized as further away from the 
endothelium (center of  blood vessel) and making an appropriate selection of  the 












Figure 4.1: Blood vessel size relative to beam size.  Larger beam sizes will facilitate 
vaporization anywhere along the span of  the vessel diameter (a), while smaller beam 


























Figure 4.2: Diagram depicting three cases where ADV could take place inside blood 
vessels using OptiCell™ chambers. Vaporization in direct contact with the 
endothelium (a), vaporization near the endothelium in an open space (b) and 

























Figure 4.3: ADV inside an open (left) versus confined (right) environments.  An 
open environment is defined as a situation where bubbles can be vaporized and 
expand fully to its spherical shape in any direction.  A confined environment 
represents a situation where bubbles are only allowed to expand in one direction. In 
both cases vaporization occurred in the wall opposite to the EC monolayer.  Scale 
















Figure 4.4: Fluorescence images depicting cell density after ADV in an open 
environment (left) and confined environment (right).  Cells were stained with 











Figure 4.5: Total cell fraction after ADV for an open versus a confined environment.  
Control group (line hatch) represents the treatments with droplets, but no ADV.  All 
data is normalized to our negative control (no droplets, no ultrasound).  Open case 






Figure 4.6: ADV and associated damages for vaporization at the EC monolayer (top 
row) versus vaporization away from the EC monolayer, but in confined environment 








Figure 4.7: Total cell fraction (TCF) for the cases presented in Figure 4.2.  Case (a) 
corresponds to vaporization at the EC monolayer as presented in chapters 2 and 3.  
Cases (b) and (c) correspond to vaporization in an open environment (Rd/Rv = 0.03) 







This dissertation has presented the effects of  ADV on an idealized endothelial 
monolayer while varying acoustic parameters, such as pressure, pulse length and 
carrier frequency.  Proximity and confinement of  ADV were also investigated.  To 
the best of  our knowledge this is the first study that shows the ADV-endothelial 
interaction and effects under acoustic conditions applicable to GE and the 
implications of  such effects during and after treatment.  For the conditions tested in 
this study, these are the main findings of  this work:  
 ADV in direct contact with ECs will cause cell damage and detachment.   
 Cell damage is dependent on the BCA 
 Damage to ECs is highly localized.  No damage was found beyond the BCA 
when vaporization happened in direct contact with the cells. 
 A combination of  pressure, pulse length and frequency determine the BCA 
and hence the degree of  damage. 
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o Greater spatial peak intensities (determined by pressure amplitude and 
time) translate to grater effects.   
o The pressure contribution to BCA changes with frequency.  Greater 
contribution is seen for lower frequencies and vice versa.  
o BCAs are limited by the size of  the beam width.  
 For a given intensity, the 7.5 MHz transducer caused more damage than the 
3.5 MHz transducer relative to their own beam widths. 
 Droplet size to gap size ratio is important in the generation of  pressures and 
stresses capable of  affecting ECs. 
o Greater ratios translated to greater effects. 
 Vaporizing away from the ECs, but in a confined environment produces 
greater effects than vaporizing in direct contact to the cells. 
 High pressures may have a major role in cell damage when compared to shear 
stresses.  Shear stresses may become more important at longer time scales. 
 Though unlikely for the 7.5 MHz transducer, IC is still a possible cause of  
death, especially for the 3.5 MHz transducer.      
Under physiological conditions, EC will sense shear stresses and other 
mechanical stimuli to respond to meet metabolic needs [38].  They can also adapt 
by upregulating growth factors, cytoskeletal reorganization, among other activities.  
However, if  these stresses are altered beyond physiological conditions ECs functions 
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could be impaired [23].  Risks of  thrombus formation, fat accumulation, and 
atherosclerosis are major consequences of  endothelial dysfunction from which GE 
could benefit.  Damage to the endothelium could induce thrombosis at the site of  
vaporization providing additional occlusion to those affected vessels.  Controlled 
impairment of  endothelial functions like permeability could also aid in the delivery 
of  drugs or other substances that will need to cross the endothelial barrier during 
treatments.  In other words, if  controlled, not only could ADV provide a localized 
embolus to a specific location in the vasculature, but could also provide a mechanism 
for triggering local drug delivery following occlusion given that cell viability can be 
sustained.  
Our data have shown that ADV events occurring in close proximity to ECs as 
well as in confined environments will cause a decrease cell viability and/or 
attachment.  However cell repopulation can happen depending on the growth 
conditions.  In summary, we have found a range of  results that provide an insight 
into the potential bioeffects of  GE during ADV that not only could help us prevent 
damage, but could aid in the optimization of  this therapy and other clinical 
applications.  




Recommendations and Future Work 
 
 
The results presented in this dissertation were obtained from controlled in vitro 
experiments simulating a worst-case scenario.  In vivo situations are often times 
difficult to mimic.  The addition of  all the necessary parameters to closely simulate 
these conditions does not allow for a controlled experiment.  Therefore, several 
variables were not considered to facilitate the explanation of  our results.   This 
study presented an idealized model in which a monolayer of  HUVECs attached to 
fibronectin was used in a static environment.  Flow of  bulk fluid, RBCs and 
transport of  macromolecules are a few of  the characteristics of  a blood vessel that 
were omitted in this study.  In particular, flow was not considered as the flow in 
target vessels is much slower than the firing frequency of  the US.  Also, the 
endothelium is supported by an extracellular matrix composed of  a mesh of  different 
proteins and other different layers of  cells with different mechanical properties.  We 
believe that the anchor these cells are attached to is an important parameter in 
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determining the likelihood of  cell detachment and as such would have different 
effects depending on its composition.  Laminin, collagen, proteoglycans and other 
important growth factors are some of  the additional proteins that make up the 
basement membrane where endothelial cells are attached to.  In addition, the 
cellular response from ECs may vary depending on their origin in the vascular tree as 
well as their initial pathological state [39].  ECs showing an initial diseased state 
may be more vulnerable to cellular injury and altered response when compared to a 
healthy cell population.              
A proposed extension to this work is the study of  how droplets behave in flow at 
physiological conditions and how these lead to interaction between the droplet 
albumin shell and the endothelium.  Preliminary studies showed that ECs have an 
affinity for albumin-coated DDFP droplets (Figure 6.1) , perhaps due to an albumin 
receptor previously described elsewhere [57, 73].  Albumin is the major blood 
protein in charge of  controlling the oncotic pressure influencing transendothelial 
fluxes of  water and other small molecules across the vessel wall.  It can also be 
transported across the endothelium, may reduce platelet adhesion and restrict surface 
binding of  other plasma proteins.  A group from the Yale School of  Medicine found 
a 60-kDa endothelial glycoprotein that is believed to be directly involved in a specific 
interaction with albumin [73].  Activation of  this glycoprotein (gp60) led to albumin 
uptake by the endothelium of  microvessels as well as transport via a transcellular 
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pathway [58].  These characteristics make an albumin-coated droplet a great 
candidate for direct interaction with the endothelium facilitating vaporization at the 
endothelial surface and perhaps aiding in other therapies as localized drug delivery.  
A flow chamber has previously been used for this purpose (Figure 6.2) and 
preliminary results point at a settlement of  these droplets in slow flow (low shear) 
conditions allowing for these to interact with the endothelium and eventually 
attaching to the endothelial surface (Figure 6.3). 
It would also be pertinent to include an in vivo experiment in which significant 
vaporization is carried out inside an animal model to quantify the number of  
circulating endothelial cells in blood.  Circulating endothelial cells (CEC) have been 
used in the past as an indicator of vascular disease, endothelial dysfunction and cancer.  
CECs can be found in the bloodstream and can be quantified by a number of methods 
including immunocytochemistry and flow cytometry.  Quantifying CECs after ADV 
events can asses both the likelihood and strength of ADV events taking place near the 
endothelium.  A high number of CEC compared to controls will be an indication that 
ADV has indeed hindered the EC attachment to the vascular wall and hence its function.    
Ultra-high speed experiments in which ADV events are limited to a single cell 
could also aid in the elucidation of  the actual mechanism of  injury.  This method 
may allow us to observe any indication of  cavitation (collapse or jet formation) or 
perhaps how bubble expansion directly affects the cell membrane.  Other parameters 
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like droplet size are believed to affect the degree of  damage and should also be 
studied.  However, for this case a monodisperse solution of  droplets may be needed.  
Monodisperse droplet solutions are currently being developed, but high throughput 
to meet the desired concentrations is still a challenge.  This study only considered 
one pulse, but in fact longer pulses or the inclusion of  pulse repetition frequency 
(PRF) may be needed in clinical practice to increase the number of  vaporized 
droplets in the vasculature and increase the probability of  occlusion.  However 
idealized this model is to address the many questions regarding the effectiveness of  
ADV and GE as a whole, this has served as a platform for subsequent studies aiming 
















Figure 6.1: Endothelial cell culture with a solution of  albumin-coated DDFP droplets.  
After two rinses with PBS droplets were removed from intercellular spaces but 
remained attached on the cell surface.  Addition of  free albumin to the PBS solution 









Figure 6.2: Proposed setup for the study of  droplet-endothelial interaction.  A 
syringe pump will withdraw cell media from one of  the reservoirs to prime the lines 
and the channel.  A second reservoir connected through a three-way valve and 
containing the droplet solution continuously stirred will be used to introduce them 
into the system.  An extra three-way valve connected to a syringe may be used to 












Figure 6.3: Preliminary results depicting the effects of  shear stress in droplet 
settlement under flow conditions.  Before and after pictures show results for 2 







Statistical Analysis - Chapter 2 
 




BCA  =  -0.799869 + 0.320643 Pressure + 0.0037073 Cycles + 0.000588616 
        Pressure*Cycles 
 




Term                  Coef   SE Coef        T      P 
Constant         -0.799869  0.110180  -7.2596  0.000 
Pressure          0.320643  0.020342  15.7623  0.000 
Cycles            0.003707  0.010459   0.3545  0.724 
Pressure*Cycles   0.000589  0.001927   0.3055  0.761 
 
Interpretation: We reject the null hypothesis that the pressure coefficient = 0.  
Pressure is a significant factor in the linear model and strongly changes the response, 
BCA (bubble cloud area).  There’s not enough evidence to reject the null hypothesis 
that the coefficient for Cycles or Pressure*Cycles = 0.  Therefore, these do not 




Summary of Model 
 
S = 0.202975     R-Sq = 93.30%        R-Sq(adj) = 93.05% 
PRESS = 3.75391  R-Sq(pred) = 92.64% 
 
Interpretation: This model can explain 93% of  the variation in BCA.  The extra 7% 
is not explained by this model and may be due to other sources of  variations not 
accounted for in the model and error.
 
Analysis of Variance 
 
Source             DF   Seq SS   Adj SS   Adj MS        F         P 
Regression          3  47.5801  47.5801  15.8600  384.962  0.000000 
  Pressure          1  47.4824  10.2359  10.2359  248.450  0.000000 
  Cycles            1   0.0938   0.0052   0.0052    0.126  0.723900 
  Pressure*Cycles   1   0.0038   0.0038   0.0038    0.093  0.760746
 
Error              83   3.4195   3.4195   0.0412 
  Lack-of-Fit       8   1.5004   1.5004   0.1876    7.330  0.000000 
  Pure Error       75   1.9191   1.9191   0.0256 
Total              86  50.9996 
 
Interpretation: Confirmation of  the linear model.  The regression fits our data 
(p<0.05), pressure is a significant factor affecting the response (p<0.05), while other 
factors or interactions are not important (p>0.05).  However, due to a lack-of-fit in 
the regression model, another model may be more adequate.  This is in part due to 
the lack of  error in the measurements for one pressure value where all responses were 
equal to 0.  For our experiments, BCA is a threshold phenomenon, dependent on 
pressure, thus the BCA below the threshold are known and equal to 0.    
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Fits and Diagnostics for Unusual Observations 
 
Obs      BCA      Fit     SE Fit   Residual  St Resid 
 61  1.70473  1.18190  0.0248204   0.522824   2.59528  R 
 73  1.39593  1.89994  0.0616738  -0.504009  -2.60633  R 
 75  2.30320  1.79894  0.0534196   0.504254   2.57510  R 
 84  2.27048  1.83261  0.0379038   0.437875   2.19591  R 
 
R denotes an observation with a large standardized residual. 
 
The following model fixes the lack-of-fit encountered in the first model by excluding 
BCA = 0 and parameters that were not significant in predicting the value of BCA.  




BCA  =  -1.21491 + 0.393339 Pressure 
 
63 cases used, 25 cases contain missing values  
Coefficients 
 
Term          Coef    SE Coef         T      P 
Constant  -1.21491  0.0956495  -12.7017  0.000 
Pressure   0.39334  0.0153193   25.6760  0.000 
 
Summary of Model 
 
S = 0.196145     R-Sq = 91.53%        R-Sq(adj) = 91.39% 
PRESS = 2.48821  R-Sq(pred) = 91.02% 
 
Analysis of Variance 
 
Source         DF   Seq SS   Adj SS   Adj MS        F         P 
Regression      1  25.3635  25.3635  25.3635  659.259  0.000000 
  Pressure      1  25.3635  25.3635  25.3635  659.259  0.000000 
Error          61   2.3468   2.3468   0.0385 
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  Lack-of-Fit   1   0.0607   0.0607   0.0607    1.593  0.211771 
  Pure Error   60   2.2861   2.2861   0.0381 
Total          62  27.7103 
 
Interpretation: This is a better model that fits and explains our data.  The lack-of-fit 
is not significant; therefore this is a more adequate model. 
 
Fits and Diagnostics for Unusual Observations 
 
Obs      BCA      Fit     SE Fit   Residual  St Resid 
 46  1.56605  1.14512  0.0247167   0.420933   2.16328  R 
 47  1.55069  1.14512  0.0247167   0.405565   2.08430  R 
 61  1.70473  1.14512  0.0247167   0.559605   2.87594  R 
 73  1.39593  1.93180  0.0389851  -0.535871  -2.78764  R 
 78  1.48633  1.93180  0.0389851  -0.445468  -2.31735  R 
 
R denotes an observation with a large standardized residual. 
 
Interpretation: These observations with large residuals are likely to be outliers.   
 
 
Figure A.A. 1: This figure shows the fitted line through the data with 95% confidence 
interval (CI) and 95 % prediction interval (PI).  The confidence interval gives us 
information on probability of  finding the mean, while the prediction interval gives us 
probability of  finding the scattered data.  We can explain ~91% of  the variation 



















BCA =  - 1.215 + 0.3933 Pressure
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We can use this model to estimate the value of  BCA at pressures between 4 and 8 
MPa. 
 
General Regression Analysis: tcc versus press, cyc in R 
 
Call: 
lm(formula = tcc ~ press * cyc * drop, data = pcd) 
 
Residuals: 
    Min      1Q  Median      3Q     Max  
-669.68  -96.12   16.90  123.11  455.10  
 
Coefficients: 
                Estimate Std. Error t value Pr(>|t|)     
(Intercept)    2678.2220    64.1534  41.747  < 2e-16 *** 
press            -1.9057    13.9015  -0.137  0.89113     
cyc              -2.8449     7.4194  -0.383  0.70187     
drop            -96.0977    87.7277  -1.095  0.27490     
press:cyc         0.6562     1.5088   0.435  0.66418     
press:drop      -86.1627    19.0498  -4.523 1.14e-05 *** 
cyc:drop         33.1371    10.1478   3.265  0.00132 **  
press:cyc:drop   -9.5386     2.0633  -4.623 7.48e-06 *** 
--- 
Signif. codes:  0 ‘***’ 0.001 ‘**’ 0.01 ‘*’ 0.05 ‘.’ 0.1 ‘ ’ 1 
 
Residual standard error: 200.3 on 169 degrees of freedom 
  (2 observations deleted due to missingness) 
Multiple R-squared:  0.8272,    Adjusted R-squared:   0.82  
F-statistic: 115.5 on 7 and 169 DF,  p-value: < 2.2e-16 
 
Interpretation:  Pressure (press), cycles (cyc) and droplets (drop) do not contribute to 
our regression model (p>0.05).  This does not mean that they have no effect in the 
response, tcc (total cell count).  Other parameters are better at explaining the 
changes in tcc.  We reject the null hypothesis that the coefficients are equal to zero 
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for the following interaction terms: press*drop, cyc*drop and press*cyc*drop.  
These terms have a strong significant effect on estimating our response.  We can 
explain 82% of  the variation with this model, while the rest is due to other factors not 
included in the model and error.  This regression significantly fits our data (p<0.05).  
 
> anova(model1) 
Analysis of Variance Table 
Response: tcc 
                Df   Sum Sq  Mean Sq  F value    Pr(>F)     
press            1  7601046  7601046 189.3951 < 2.2e-16 *** 
cyc              1    66893    66893   1.6668    0.1985     
drop             1 16070320 16070320 400.4238 < 2.2e-16 *** 
press:cyc        1   767023   767023  19.1119 2.148e-05 *** 
press:drop       1  7055861  7055861 175.8107 < 2.2e-16 *** 
cyc:drop         1    39483    39483   0.9838    0.3227     
press:cyc:drop   1   857742   857742  21.3723 7.481e-06 *** 
Residuals      169  6782523    40133                        
--- 
Signif. codes:  0 ‘***’ 0.001 ‘**’ 0.01 ‘*’ 0.05 ‘.’ 0.1 ‘ ’ 1 
 
Interpretation:  Pressure and droplets significantly affect the tcc (p<0.05).  Note 
how these have an effect on the response, but cannot be used to estimate the value of  
tcc in the regression.  Cyc and cyc*drop are not significant, meaning that changing 
cycles have no effect on the response even in the presence of  droplets.  However, 















0 0 0 
2 2, 4 0 
3 2, 8 0 
1 2, 16 0 
5 4, 4 0 
6 4, 8 0 
4 4, 16 0 
8 6, 4 0 
9 6, 8 0 
7 6, 16 0 
11 8, 4 0 
12 8, 8 0 
10 8, 16 0 
13 0 1 
15 2, 4 1 
16 2, 8 1 
14 2, 16 1 
18 4, 4 1 
19 4, 8 1 
17 4, 16 1 
21 6, 4 1 
22 6, 8 1 
20 6, 16 1 
24 8, 4 1 
25 8, 8 1 





Source      DF        SS       MS      F      P 
Treatment   25  34096931  1363877  40.04  0.000 
Error      151   5143960    34066 
Total      176  39240891 
 




All treatments have been code to be compared to our control 
 
                         Individual 95% CIs For Mean Based on 
                         Pooled StDev 
Level  N    Mean  StDev  -------+---------+---------+---------+-- 
 0     7  2637.9  165.7                             (--*--) 
 1     7  2684.7  166.4                              (--*-) 
 2     6  2767.3  177.7                               (--*--) 
 3     7  2623.0  174.9                             (-*--) 
 4     6  2571.3  155.7                           (--*--) 
 5     6  2673.3  132.6                             (--*--) 
 6     5  2727.2  159.1                              (---*--) 
 7     6  2717.2  131.7                              (--*--) 
 8     8  2670.4  155.4                              (-*--) 
 9     6  2637.0  264.8                             (--*--) 
10     6  2739.7  220.6                               (--*--) 
11     6  2697.2   83.1                              (--*--) 
12     6  2622.7  104.6                            (--*--) 
13     8  2455.8  148.8                          (-*--) 
14     8  2494.0  182.3                          (--*-) 
15     7  2484.4   97.7                          (--*-) 
16     8  2471.1  235.9                          (-*--) 
17     7  2251.4  189.9                     (--*--) 
18     7  2409.6  180.5                        (--*--) 
19     7  2319.0  154.4                       (-*--) 
20     7  1615.4  328.6         (-*--) 
21     8  2118.5  126.3                   (-*--) 
22     7  1885.0  226.7              (--*-) 
23     7  1298.9  168.4  (--*--) 
24     7  1555.6  193.9       (--*--) 
25     7  1360.1  248.1   (--*--) 
                         -------+---------+---------+---------+-- 
                             1500      2000      2500      3000 
 
Pooled StDev = 184.6 
 





Level         N    Mean  Grouping 
 0 (control)  7  2637.9  A 
 2            6  2767.3  A 
10            6  2739.7  A 
 6            5  2727.2  A 
 7            6  2717.2  A 
11            6  2697.2  A 
 1            7  2684.7  A 
 5            6  2673.3  A 
 8            8  2670.4  A 
 9            6  2637.0  A 
 3            7  2623.0  A 
12            6  2622.7  A 
 4            6  2571.3  A 
14            8  2494.0  A 
15            7  2484.4  A 
16            8  2471.1  A 
13            8  2455.8  A 
18            7  2409.6  A 
19            7  2319.0  A 
17            7  2251.4  A 
21            8  2118.5 
22            7  1885.0 
20            7  1615.4 
24            7  1555.6 
25            7  1360.1 
23            7  1298.9 
 
Means not labeled with letter A are significantly different from control 
level mean. 
 
The following treatments were significantly different from the control: all treatments 







Dunnett's comparisons with a control 
 
Family error rate = 0.05 
Individual error rate = 0.0031 
 
Critical value = 3.01 
Control = level (0) of Treatment 
 
General Regression Analysis: dcc versus press, cyc in R 
 
Call: 
lm(formula = dcc ~ press * cyc * drop, data = pcd) 
 
Residuals: 
    Min      1Q  Median      3Q     Max  
-68.830 -11.802  -2.965   6.577 131.045  
 
Coefficients: 
               Estimate Std. Error t value Pr(>|t|)   
(Intercept)    21.76423    9.64741   2.256   0.0254 * 
press           0.02414    2.04796   0.012   0.9906   
cyc            -0.33140    1.08777  -0.305   0.7610   
drop           23.00973   12.94145   1.778   0.0772 . 
press:cyc       0.05977    0.21920   0.273   0.7854   
press:drop      3.68790    2.76793   1.332   0.1846   
cyc:drop       -2.27016    1.48769  -1.526   0.1289   
press:cyc:drop  0.53667    0.29897   1.795   0.0745 . 
--- 
Signif. codes:  0 ‘***’ 0.001 ‘**’ 0.01 ‘*’ 0.05 ‘.’ 0.1 ‘ ’ 1 
 
Residual standard error: 28.56 on 167 degrees of freedom 
  (4 observations deleted due to missingness) 
Multiple R-squared:  0.4812,    Adjusted R-squared:  0.4594  
F-statistic: 22.13 on 7 and 167 DF,  p-value: < 2.2e-16 
 
Interpretation: We fail to reject the null hypothesis that the coefficients are equal to 
zero.  We cannot fit a line through our data.  We can only explain 46% of  the 
111 
 
variation with this model.  
 
> anova(model2) 
Analysis of Variance Table 
 
Response: dcc 
                Df Sum Sq Mean Sq  F value    Pr(>F)     
press            1  21747   21747  26.6603 6.833e-07 *** 
cyc              1     42      42   0.0518   0.82018     
drop             1  82210   82210 100.7834 < 2.2e-16 *** 
press:cyc        1   4069    4069   4.9884   0.02685 *   
press:drop       1  15649   15649  19.1847 2.089e-05 *** 
cyc:drop         1      3       3   0.0032   0.95508     
press:cyc:drop   1   2628    2628   3.2222   0.07446 .   
Residuals      167 136224     816                        
--- 
Signif. codes:  0 ‘***’ 0.001 ‘**’ 0.01 ‘*’ 0.05 ‘.’ 0.1 ‘ ’ 1 
 
Interpretation:  Pressure significantly affectsBCA the response, dcc (dead cell count).  
The means for the group containing droplets and that without droplets are 
significantly different (drop p<0.05).  Pressure interacts with both cycles and 
droplets. 
 
One-way ANOVA: Dead Cells versus Treatment in Minitab 16 
 
Source      DF      SS    MS     F      P 
Treatment   25  137934  5517  6.60  0.000 
Error      149  124639   837 
Total      174  262573 
 
S = 28.92   R-Sq = 52.53%   R-Sq(adj) = 44.57% 
 




Level  N    Mean  StDev  --+---------+---------+---------+------- 
 0     6   23.00   7.29    (------*-----) 
 1     7   20.71   4.03    (-----*-----) 
 2     6   18.33   5.50   (-----*------) 
 3     7   20.29   4.31    (-----*-----) 
 4     6   17.33   4.68  (------*------) 
 5     6   21.50   5.36   (------*------) 
 6     6   23.50   7.34    (------*-----) 
 7     6   20.67  12.58   (------*------) 
 8     8   20.88   6.17    (-----*-----) 
 9     6   21.00   8.69   (------*------) 
10     6   27.00  17.87     (------*-----) 
11     6   25.50   6.44     (-----*------) 
12     6   21.00   8.32   (------*------) 
13     8   50.13  19.61             (----*-----) 
14     7   30.86  22.65       (-----*-----) 
15     6   32.50  13.92       (-----*------) 
16     8   50.88  28.42             (-----*----) 
17     7   52.71  24.62             (-----*-----) 
18     7   66.43  56.38                 (-----*-----) 
19     7   31.00  20.23       (-----*-----) 
20     7   98.29  43.39                          (-----*-----) 
21     8   67.88  62.75                  (----*-----) 
22     7   82.14  46.67                     (-----*------) 
23     7  103.00  38.54                           (-----*------) 
24     7   93.14  36.48                        (------*-----) 
25     7   84.71  47.48                      (-----*-----) 
                         --+---------+---------+---------+------- 
                           0        35        70       105 
 
Pooled StDev = 28.92 
 








Grouping Information Using Dunnett Method 
 
Level         N    Mean  Grouping 
 0 (control)  6   23.00  A 
23            7  103.00 
20            7   98.29 
24            7   93.14 
25            7   84.71 
22            7   82.14 
21            8   67.88  A 
18            7   66.43  A 
17            7   52.71  A 
16            8   50.88  A 
13            8   50.13  A 
15            6   32.50  A 
19            7   31.00  A 
14            7   30.86  A 
10            6   27.00  A 
11            6   25.50  A 
 6            6   23.50  A 
 5            6   21.50  A 
12            6   21.00  A 
 9            6   21.00  A 
 8            8   20.88  A 
 1            7   20.71  A 
 7            6   20.67  A 
 3            7   20.29  A 
 2            6   18.33  A 
 4            6   17.33  A 
 
Means not labeled with letter A are significantly different from control 
level mean. 
 
The following treatments were significantly different from the control: 6, 8; 6, 16 and 





Dunnett's comparisons with a control 
 
Family error rate = 0.05 
Individual error rate = 0.0033 
 
Critical value = 2.99 
 





Statistical Analysis - Chapter 3 
 




BCA  =  -0.0396519 + 0.0206116 Pressure - 0.00894162 Cycle + 0.00591338 





Term                  Coef    SE Coef         T      P 
Constant        -0.0396519  0.0423412  -0.93649  0.353 
Pressure         0.0206116  0.0107619   1.91524  0.060 
Cycle           -0.0089416  0.0035897  -2.49089  0.015 
Pressure*Cycle   0.0059134  0.0009316   6.34747  0.000 
 
 
Summary of Model 
 
S = 0.0380491     R-Sq = 89.10%        R-Sq(adj) = 88.58% 
PRESS = 0.100580  R-Sq(pred) = 87.79% 
 
 
Analysis of Variance 
 
Source            DF    Seq SS    Adj SS    Adj MS        F          P 
Regression         3  0.734028  0.734028  0.244676  169.006  0.0000000 
  Pressure         1  0.409925  0.005310  0.005310    3.668  0.0600778 
  Cycle            1  0.265773  0.008982  0.008982    6.205  0.0154341 
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  Pressure*Cycle   1  0.058330  0.058330  0.058330   40.290  0.0000000 
Error             62  0.089759  0.089759  0.001448 
  Lack-of-Fit      7  0.032532  0.032532  0.004647    4.466  0.0005415 
  Pure Error      55  0.057228  0.057228  0.001041 
Total             65  0.823788Fits and Diagnostics for Unusual Observations 
 
Obs      NBCA       Fit     SE Fit   Residual  St Resid 
 49  0.314321  0.393411  0.0125392  -0.079089  -2.20160  R 
 64  0.338533  0.228408  0.0079917   0.110125   2.96031  R 
 65  0.351069  0.228408  0.0079917   0.122661   3.29730  R 
 
R denotes an observation with a large standardized residual. 
 
This model tries to predict the value of  bubble cloud area (BCA) given the 
parameters Pressure and Cycle.  P-values below 0.05 tell us which parameters 
contribute significantly to the model.  Cycle and Pressure*Cycle contribute 
significantly.  Pressure alone or the constant do not contribute significantly in 
making a prediction of  BCA.   A negative constant would be absurd to consider in 
this model given that when both Pressure and Cycle are equal to zero this would 
yield a negative BCA, which is not physically possible.  This term should be 
removed from the model.  The (adj) R-Sq tells us that we can explain ~88% of  the 
variation in BCA with this model.  The rest of  the variation can be explained by 
other parameters not accounted for in this model and other uncontrollable sources of  
error.  Further investigation and analysis would be needed to determine other 
sources of  the variation. The ANOVA table tells us which parameters caused a 
significant effect on the mean of  the response (BCA).  Parameters with p-values 
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below 0.05 significantly affect the mean.  A significant interaction tells us that the 
change in the mean is different depending on the selected levels (values) for both 
Pressure and Cycle.  In other words the effects of  Pressure depend on the value of  
Cycle.  A lack-of-fit test reveals that the model presented here may not be adequate.  
Mainly that a linear regression does not adequately fit the data.  Higher order terms 
(quadratic) should be considered to fix this model in order to make better predictions, 
but further investigation and resources may be needed.  Lastly, three observations 
with rather large residuals may suggest the presence of  outliers (mistyped data, 
different units).  After checking the input data it was determined that this are in fact 
the true measured values. 
 





4    BCA  =  -0.0837196 + 0.0407188 Pressure 
 
8    BCA  =  -0.128751 + 0.0801653 Pressure 
 





Term                Coef    SE Coef         T      P 
Constant      -0.0837196  0.0367809  -2.27617  0.026 




  8           -0.0450314  0.0423220  -1.06402  0.292 
  16          -0.0931429  0.0423220  -2.20081  0.032 
Pressure*Cyc 
  8            0.0394465  0.0106601   3.70038  0.000 
  16           0.0704246  0.0106601   6.60637  0.000 
 
 
Summary of Model 
 
S = 0.0312096      R-Sq = 92.91%        R-Sq(adj) = 92.31% 
PRESS = 0.0701498  R-Sq(pred) = 91.48% 
 
 
Analysis of Variance 
 
Source          DF    Seq SS    Adj SS    Adj MS        F         P 
Regression       5  0.765345  0.765345  0.153069  157.148  0.000000 
  Pressure       1  0.409925  0.019896  0.019896   20.427  0.000030 
  Cyc            2  0.310846  0.005529  0.002765    2.838  0.066403 
  Pressure*Cyc   2  0.044574  0.044574  0.022287   22.881  0.000000 
Error           60  0.058442  0.058442  0.000974 
  Lack-of-Fit    5  0.001215  0.001215  0.000243    0.233  0.946181 
  Pure Error    55  0.057228  0.057228  0.001041 
Total           65  0.823788 
 
Fits and Diagnostics for Unusual Observations 
 
Obs       BCA       Fit     SE Fit    Residual  St Resid 
 13  0.236667  0.156568  0.0069787   0.0800989   2.63315  R 
 31  0.347248  0.267711  0.0069787   0.0795365   2.61466  R 
 49  0.314321  0.378855  0.0106601  -0.0645335  -2.20006  R 
 61  0.211548  0.272076  0.0106601  -0.0605278  -2.06350  R 
 64  0.338533  0.272076  0.0106601   0.0664575   2.26565  R 
 65  0.351069  0.272076  0.0106601   0.0789934   2.69302  R 
 











0     TCF  =  0.987007 - 0.0130922 Pressure + 0.000764843 Cycles - 0.00032345 
              Pressure*Cycles 
 
1     TCF  =  1.07345 - 0.00828487 Pressure + 0.0143335 Cycles - 0.00804414 
              Pressure*Cycles 
 
 





Term                       Coef    SE Coef        T      P 
Constant               0.987007  0.0183809  53.6974  0.000 
Pressure              -0.013092  0.0089759  -1.4586  0.146 
Cycles                 0.000765  0.0029480   0.2594  0.796 
Drop 
  1                    0.086441  0.0250837   3.4461  0.001 
Pressure*Cycles       -0.000323  0.0010869  -0.2976  0.766 
Pressure*Drop 
  1                    0.004807  0.0120694   0.3983  0.691 
Cycles*Drop 
  1                    0.013569  0.0041541   3.2663  0.001 
Pressure*Cycles*Drop 
  1                   -0.007721  0.0014635  -5.2754  0.000 
 
 
Summary of Model 
 
S = 0.0938903    R-Sq = 55.09%        R-Sq(adj) = 53.39% 






Analysis of Variance 
 
Source                   DF   Seq SS   Adj SS    Adj MS        F         P 
Regression                7  2.01093  2.01093  0.287276  32.5880  0.000000 
  Pressure                1  1.00487  0.01875  0.018755   2.1275  0.146365 
  Cycles                  1  0.02855  0.00059  0.000593   0.0673  0.795579 
  Drop                    1  0.03379  0.10469  0.104688  11.8756  0.000703 
  Pressure*Cycles         1  0.36897  0.00078  0.000781   0.0886  0.766345 
  Pressure*Drop           1  0.31768  0.00140  0.001399   0.1586  0.690862 
  Cycles*Drop             1  0.01173  0.09405  0.094049  10.6687  0.001297 
  Pressure*Cycles*Drop    1  0.24533  0.24533  0.245334  27.8302  0.000000 
Error                   186  1.63966  1.63966  0.008815 
  Lack-of-Fit            24  0.35103  0.35103  0.014626   1.8387  0.014336 
  Pure Error            162  1.28864  1.28864  0.007955 
Total                   193  3.65059 
 
 
Fits and Diagnostics for Unusual Observations 
 
Obs      TCF      Fit     SE Fit   Residual  St Resid 
  2  0.87678  1.07345  0.0170686  -0.196671  -2.13019  R 
 33  0.98262  1.16579  0.0306133  -0.183171  -2.06368  R 
 54  1.23697  1.02880  0.0220665   0.208165   2.28100  R 
 59  0.84518  1.04986  0.0115058  -0.204678  -2.19652  R 
 68  1.10585  0.89181  0.0177995   0.214034   2.32172  R 
 77  0.81833  1.00940  0.0141308  -0.191073  -2.05851  R 
 89  0.48657  0.75482  0.0206602  -0.268248  -2.92882  R 
 96  1.08373  0.89756  0.0131453   0.186164   2.00250  R 
 97  1.12638  0.89756  0.0131453   0.228818   2.46132  R 
106  0.37915  0.61783  0.0285832  -0.238682  -2.66881  R 
117  0.61927  0.82493  0.0177127  -0.205653  -2.23041  R 
138  0.79661  0.98701  0.0183809  -0.190393  -2.06783  R 
160  0.77266  0.97568  0.0125363  -0.203024  -2.18189  R 
166  0.79063  0.97745  0.0156414  -0.186821  -2.01798  R 
183  0.76816  0.96177  0.0119287  -0.193602  -2.07885  R 
221  0.74870  0.90791  0.0337830  -0.159210  -1.81743     X 
223  0.98678  0.90791  0.0337830   0.078876   0.90039     X 
224  0.92689  0.90791  0.0337830   0.018980   0.21666     X 
227  0.77116  0.90791  0.0337830  -0.136749  -1.56103     X 
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R denotes an observation with a large standardized residual. 
X denotes an observation whose X value gives it large leverage. 
 
Results for: Control 
  




TCF  =  0.987007 - 0.0130922 Pressure + 0.000764843 Cycles - 0.00032345 
        Pressure*Cycles 
 
 




Term                  Coef    SE Coef        T      P 
Constant          0.987007  0.0174721  56.4904  0.000 
Pressure         -0.013092  0.0085321  -1.5345  0.129 
Cycles            0.000765  0.0028022   0.2729  0.786 
Pressure*Cycles  -0.000323  0.0010331  -0.3131  0.755 
 
Summary of Model 
 
S = 0.0892482     R-Sq = 8.68%         R-Sq(adj) = 5.49% 
PRESS = 0.751784  R-Sq(pred) = -0.22% 
 
Analysis of Variance 
 
Source             DF    Seq SS    Adj SS     Adj MS        F         P 
Regression          3  0.065110  0.065110  0.0217033  2.72475  0.049136 
  Pressure          1  0.064303  0.018755  0.0187546  2.35455  0.128589 
  Cycles            1  0.000026  0.000593  0.0005934  0.07450  0.785554 
  Pressure*Cycles   1  0.000781  0.000781  0.0007807  0.09801  0.754984 
Error              86  0.685011  0.685011  0.0079652 
  Lack-of-Fit      12  0.117304  0.117304  0.0097754  1.27421  0.251993 
  Pure Error       74  0.567707  0.567707  0.0076717 
Total              89  0.750121 
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Fits and Diagnostics for Unusual Observations 
 
Obs       TCF       Fit     SE Fit   Residual  St Resid 
 20  0.796615  0.987007  0.0174721  -0.190393  -2.17539  R 
 42  0.772656  0.975681  0.0119165  -0.203024  -2.29538  R 
 48  0.790625  0.977446  0.0148681  -0.186821  -2.12294  R 
 65  0.768164  0.961767  0.0113389  -0.193602  -2.18698  R 
117  0.733724  0.914727  0.0183779  -0.181003  -2.07250  R 
 
R denotes an observation with a large standardized residual. 
 
Results for: Experimental 
  




TCF  =  1.07345 - 0.00828487 Pressure + 0.0143335 Cycles - 0.00804414 
        Pressure*Cycles 
 
 




Term                 Coef    SE Coef        T      P 
Constant          1.07345  0.0177623  60.4341  0.000 
Pressure         -0.00828  0.0083966  -0.9867  0.326 
Cycles            0.01433  0.0030458   4.7061  0.000 
Pressure*Cycles  -0.00804  0.0010199  -7.8870  0.000 
 
 
Summary of Model 
 
S = 0.0977062    R-Sq = 66.78%        R-Sq(adj) = 65.78% 






Analysis of Variance 
 
Source              DF   Seq SS   Adj SS    Adj MS        F         P 
Regression           3  1.91910  1.91910  0.639700  67.0088  0.000000 
  Pressure           1  1.27891  0.00929  0.009294   0.9736  0.326175 
  Cycles             1  0.04635  0.21143  0.211426  22.1469  0.000008 
  Pressure*Cycles    1  0.59384  0.59384  0.593843  62.2053  0.000000 
Error              100  0.95465  0.95465  0.009547 
  Lack-of-Fit       12  0.23372  0.23372  0.019477   2.3774  0.010511 
  Pure Error        88  0.72093  0.72093  0.008192 
Total              103  2.87375 
 
 
Fits and Diagnostics for Unusual Observations 
 
Obs      TCF      Fit     SE Fit   Residual  St Resid 
  2  0.87678  1.07345  0.0177623  -0.196671  -2.04699  R 
 54  1.23697  1.02880  0.0229634   0.208165   2.19191  R 
 59  0.84518  1.04986  0.0119735  -0.204678  -2.11074  R 
 68  1.10585  0.89181  0.0185229   0.214034   2.23105  R 
 89  0.48657  0.75482  0.0214999  -0.268248  -2.81444  R 
 97  1.12638  0.89756  0.0136795   0.228818   2.36519  R 
106  0.37915  0.61783  0.0297449  -0.238682  -2.56458  R 
117  0.61927  0.82493  0.0184326  -0.205653  -2.14330  R 
 
R denotes an observation with a large standardized residual. 
 
Grouping Information Using Dunnett Method 
 
Level          N     Mean  Grouping 
 1 (control)  23  1.00000  A 
20             6  1.13481 
21             4  1.10269  A 
17            27  1.08028  A 
18             4  1.05845  A 
19             6  1.05161  A 
23             4  1.05095  A 
10             3  1.03071  A 
22             5  1.03033  A 
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24             5  0.99968  A 
 5             4  0.99652  A 
 9             4  0.99277  A 
29             6  0.98841  A 
 8             4  0.98753  A 
 2             5  0.96582  A 
 4             5  0.96402  A 
28             5  0.95703  A 
25             5  0.95513  A 
13             6  0.95409  A 
31             6  0.94471  A 
26             4  0.94352  A 
11             4  0.94074  A 
 6             5  0.93647  A 
12             5  0.93168  A 
15             4  0.92389  A 
 7             3  0.91691  A 
 3             6  0.89370  A 
16             5  0.88047  A 
14             4  0.85838  A 
32             5  0.80284 
27             6  0.71511 
30             6  0.57372 
 
Means not labeled with letter A are significantly different from control 
level mean. 
 
Dunnett's comparisons with a control 
 
Family error rate = 0.05 
Individual error rate = 0.0018 
 
Critical value = 3.18 








Intervals for treatment mean minus control mean 
 
Level     Lower    Center     Upper   
--+---------+---------+---------+------- 
 2     -0.17413  -0.03418   0.10577                  (-----*----) 
 3     -0.23632  -0.10630   0.02371                (----*----) 
 4     -0.17593  -0.03598   0.10397                  (-----*----) 
 5     -0.15713  -0.00348   0.15017                   (-----*-----) 
 6     -0.20348  -0.06353   0.07642                 (----*-----) 
 7     -0.25720  -0.08309   0.09101               (------*------) 
 8     -0.16612  -0.01247   0.14118                  (------*-----) 
 9     -0.16088  -0.00723   0.14642                   (-----*-----) 
10     -0.14339   0.03071   0.20481                   (------*------) 
11     -0.21291  -0.05926   0.09439                (------*-----) 
12     -0.20827  -0.06832   0.07163                 (----*-----) 
13     -0.17593  -0.04591   0.08411                  (----*----) 
14     -0.29527  -0.14162   0.01203             (-----*-----) 
15     -0.22976  -0.07611   0.07754                (-----*-----) 
16     -0.25948  -0.11953   0.02042               (----*-----) 
17     -0.00020   0.08028   0.16075                         (--*--) 
18     -0.09520   0.05845   0.21210                     (-----*-----) 
19     -0.07841   0.05161   0.18162                      (----*----) 
20      0.00479   0.13481   0.26482                         (----*-----) 
21     -0.05096   0.10269   0.25633                       (-----*-----) 
22     -0.10962   0.03033   0.17028                     (----*-----) 
23     -0.10270   0.05095   0.20460                     (-----*-----) 
24     -0.14027  -0.00032   0.13963                   (-----*-----) 
25     -0.18482  -0.04487   0.09508                  (----*-----) 
26     -0.21013  -0.05648   0.09717                 (-----*-----) 
27     -0.41490  -0.28489  -0.15487        (-----*----) 
28     -0.18292  -0.04297   0.09698                  (----*-----) 
29     -0.14160  -0.01159   0.11843                   (-----*----) 
30     -0.55629  -0.42628  -0.29626   (----*----) 
31     -0.18531  -0.05529   0.07472                  (----*----) 
32     -0.33711  -0.19716  -0.05721            (----*-----) 
                                      --+---------+---------+---------+------- 










0     DCF^0.5  =  0.0885781 + 0.0046958 Pressure - 0.000241549 Cycles - 
                  0.000282005 Pressure*Cycles 
 
1     DCF^0.5  =  0.12295 + 0.0134112 Pressure + 0.00144206 Cycles - 




Term                        Coef    SE Coef         T      P 
Constant               0.0885781  0.0140989   6.28264  0.000 
Pressure               0.0046958  0.0068781   0.68272  0.495 
Cycles                -0.0002415  0.0022260  -0.10851  0.914 
Drop 
  1                    0.0343720  0.0199318   1.72448  0.086 
Pressure*Cycles       -0.0002820  0.0007867  -0.35844  0.720 
Pressure*Drop 
  1                    0.0087154  0.0096976   0.89872  0.370 
Cycles*Drop 
  1                    0.0016836  0.0031600   0.53280  0.595 
Pressure*Cycles*Drop 
  1                   -0.0005233  0.0011261  -0.46469  0.643 
 
Summary of Model 
 
S = 0.0816880    R-Sq = 12.22%       R-Sq(adj) = 9.53% 
PRESS = 1.62611  R-Sq(pred) = 6.59% 
 
 
Analysis of Variance 
 
Source                   DF   Seq SS   Adj SS     Adj MS        F         P 
Regression                7  0.21265  0.21265  0.0303788  4.55254  0.000089 
  Pressure                1  0.01708  0.00311  0.0031103  0.46610  0.495477 
  Cycles                  1  0.00214  0.00008  0.0000786  0.01177  0.913685 
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  Drop                    1  0.17701  0.01984  0.0198441  2.97383  0.085971 
  Pressure*Cycles         1  0.00639  0.00086  0.0008574  0.12848  0.720341 
  Pressure*Drop           1  0.00808  0.00539  0.0053897  0.80770  0.369745 
  Cycles*Drop             1  0.00051  0.00189  0.0018943  0.28387  0.594691 
  Pressure*Cycles*Drop    1  0.00144  0.00144  0.0014409  0.21594  
0.642596 
Error                   229  1.52810  1.52810  0.0066729 
  Lack-of-Fit            24  0.30087  0.30087  0.0125361  2.09407  0.003085 
  Pure Error            205  1.22723  1.22723  0.0059865 
Total                   236  1.74075 
 
Fits and Diagnostics for Unusual Observations 
 
Obs   DCF^0.5       Fit     SE Fit  Residual  St Resid 
 37  0.331178  0.138908  0.0096048  0.192270   2.37015  R 
 42  0.326732  0.138908  0.0096048  0.187824   2.31535  R 
 46  0.339895  0.141455  0.0119318  0.198439   2.45557  R 
 54  0.322226  0.147076  0.0165087  0.175149   2.18930  R 
 71  0.362787  0.147603  0.0141753  0.215185   2.67481  R 
 86  0.308310  0.148129  0.0176117  0.160181   2.00811  R 
 89  0.333378  0.148129  0.0176117  0.185249   2.32238  R 
 91  0.344170  0.169479  0.0156842  0.174692   2.17907  R 
 92  0.346288  0.169479  0.0156842  0.176810   2.20548  R 
 97  0.324487  0.162362  0.0111582  0.162125   2.00346  R 
 99  0.333378  0.162362  0.0111582  0.171016   2.11334  R 
135  0.299739  0.088578  0.0140989  0.211161   2.62436  R 
172  0.350409  0.085081  0.0165184  0.265328   3.31658  R 
182  0.319097  0.091525  0.0090665  0.227572   2.80319  R 
198  0.276346  0.093965  0.0087710  0.182381   2.24564  R 
229  0.286979  0.105451  0.0203239  0.181528   2.29436  R 
 










General Regression Analysis: TCF versus NBCA, Freq  
 





0     TCF  =  1.0281 - 0.175594 NBCA 
 




Term           Coef    SE Coef        T      P 
Constant    1.02810  0.0256005  40.1593  0.000 
Freq 
  1        -0.08986  0.0310388  -2.8950  0.008 
NBCA       -0.17559  0.0271881  -6.4585  0.000 
Freq*NBCA 
  1        -0.01075  0.0318473  -0.3376  0.739 
 
 
Summary of Model 
 
S = 0.701335     R-Sq = 89.35%        R-Sq(adj) = 87.96% 
PRESS = 18.3296  R-Sq(pred) = 82.74% 
 
 
Analysis of Variance 
 
Source         DF   Seq SS   Adj SS   Adj MS        F         P 
Regression      3   94.892  94.8924  31.6308  64.3071  0.000000 
  Freq          1   12.278   4.1225   4.1225   8.3813  0.008165 
  NBCA          1   82.558  20.5170  20.5170  41.7122  0.000001 
  Freq*NBCA     1    0.056   0.0561   0.0561   0.1140  0.738704 
Error          23   11.313  11.3130   0.4919 
  Lack-of-Fit  18   10.756  10.7557   0.5975   5.3602  0.036046 
  Pure Error    5    0.557   0.5574   0.1115 





Fits and Diagnostics for Unusual Observations 
 
Obs       TCF       Fit     SE Fit   Residual  St Resid 
 15  0.543804  0.607237  0.0516042  -0.063433  -1.13872     X 
 16  0.929513  0.938240  0.0175505  -0.008728  -0.46704     X 
 22  0.792606  0.689793  0.0162534   0.102812   3.55943  R 
 
R denotes an observation with a large standardized residual. 







Statistical Analysis - Chapter 4 
 
Two-Sample T-Test and CI  
 
Sample   N   Mean  StDev  SE Mean 
1       16  1.080  0.300    0.075 
2       16  1.120  0.300    0.075 
 
 
Difference = mu (1) - mu (2) 
Estimate for difference:  -0.040 
95% CI for difference:  (-0.257, 0.177) 




Two-Sample T-Test and CI  
 
Sample   N   Mean  StDev  SE Mean 
1       16  1.080  0.300    0.075 
2       16  1.030  0.190    0.048 
 
 
Difference = mu (1) - mu (2) 
Estimate for difference:  0.0500 
95% CI for difference:  (-0.1328, 0.2328) 







Two-Sample T-Test and CI  
 
Sample   N   Mean  StDev  SE Mean 
1       16  1.120  0.300    0.075 
2       16  0.170  0.110    0.028 
 
 
Difference = mu (1) - mu (2) 
Estimate for difference:  0.9500 
95% CI for difference:  (0.7822, 1.1178) 
T-Test of difference = 0 (vs not =): T-Value = 11.89  P-Value = 0.000  DF 
= 18 
 
Two-Sample T-Test and CI  
 
Sample   N   Mean  StDev  SE Mean 
1        9  0.600  0.120    0.040 
2       16  1.030  0.190    0.048 
 
 
Difference = mu (1) - mu (2) 
Estimate for difference:  -0.4300 
95% CI for difference:  (-0.5588, -0.3012) 
T-Test of difference = 0 (vs not =): T-Value = -6.92  P-Value = 0.000  DF 
= 22 
 
Two-Sample T-Test and CI  
 
Sample   N   Mean  StDev  SE Mean 
1        9  0.600  0.120    0.040 
2       16  0.170  0.110    0.028 
 
 
Difference = mu (1) - mu (2) 
Estimate for difference:  0.4300 
95% CI for difference:  (0.3265, 0.5335) 









Figure A.D. 1: Beam profiles for both transducers.  The y-axis corresponds to a 




Figure A.D. 2: Ultrasound pulse for the 3.5 MHz transducer with a 4 (top) and 16 
(bottom) input cycle.  The y-axis shows pressure at the focus of  the transducer.  
Note that the output signal shows one less cycle compared to the input due to 




Figure A.D. 3: Ultrasound pulse from the 7.5 MHz transducer with 4 (top) and 16 
(bottom) input cycles.  The y-axis shows pressure at the focus of  the transducer.  
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